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1157 
SILENCE IS GOLDEN . . . EXCEPT IN HEALTH CARE 
PHILANTHROPY 
Stacey A. Tovino * 
INTRODUCTION 
Imagine a forty-year-old woman who has been diagnosed with 
stage IV colorectal cancer and who has less than a ten percent 
chance of living five years from the date of her diagnosis. The 
woman’s physician, who specializes in oncology and practices at a 
hospital affiliated with a major academic medical center, recom-
mends a combination of surgery, chemotherapy, and radiation to 
treat the woman’s cancer. This article addresses the permissible 
scope of uses and disclosures of the woman’s individually identifi-
able health information that may be made by the hospital and the 
physician for the purpose of attempting to raise funds for the 
hospital’s own benefit. 
If, five years after her diagnosis, the woman is still alive and 
has no evidence of disease, should the hospital be permitted to se-
lect the woman, based on her treatment in the oncology depart-
ment, her excellent outcome, and her presumed gratitude, to re-
ceive a telephone call or a letter at her home requesting a 
monetary donation that would be used to improve the infrastruc-
 
*  Lincy Professor of Law, William S. Boyd School of Law, University of Nevada, Las 
Vegas. Ph.D., University of Texas Medical Branch; J.D., University of Houston Law Cen-
ter; B.A., Tulane University. I thank Nancy Rapoport, Interim Dean, and Daniel Hamil-
ton, Dean, William S. Boyd School of Law, for their financial support of this research pro-
ject. I also thank William J. Winslade (James Wade Rockwell Professor of Medicine, 
University of Texas Medical Branch) for his comments on an earlier presentation of this 
article, and Jeanne Price (Director, Wiener-Rogers Law Library), Chad Schatzle (Student 
Services Librarian, Wiener-Rogers Law Library), Jennifer Gross (Reference and Collection 
Management Librarian, Wiener-Rogers Law Library), Bryn Esplin (3L and President, 
Health Law Society, Boyd School of Law), and Danny Gobaud (3L, Boyd School of Law) for 
their outstanding assistance in locating many of the sources referenced in this article. I 
further thank the participants of the 66th Annual Meeting of the Southeastern Associa-
tion of Law Schools in Palm Beach, Florida, for their helpful comments and suggestions on 
earlier presentations and versions of this article. 
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ture of, and the medical technology and human resources availa-
ble through, the hospital’s oncology department? In addition, 
when the woman visits the hospital for follow-up cancer screen-
ings, should her physician be permitted to initiate private conver-
sations with her regarding the hospital’s philanthropic needs? On 
the other hand, if the woman’s condition deteriorates or she dies 
within five years of her diagnosis, should the hospital be able to 
use the woman’s poor health or the fact of her death to screen her 
or her family members out from the receipt of philanthropy-
related communications? Or, due to legal and ethical concerns as-
sociated with patient confidentiality, should the hospital and 
physician be prohibited from engaging in any of the fundraising 
activities described in this paragraph? 
On January 25, 2013, the federal Department of Health and 
Human Services (“HHS”) issued final regulations (“Final Regula-
tions”)
1
 modifying the privacy rule (“Privacy Rule”)
2
 that imple-
ments section 264 of the administrative simplification provisions
3
 
within the Health Insurance Portability and Accountability Act of 
1996 (“HIPAA”).
4
 These Final Regulations changed the answers 
to some of the questions raised above. More recently, on Septem-
ber 16, 2013, HHS issued a model notice of privacy practices 
(“Model Notice”) that would provide patients with little infor-
mation regarding how their health care providers use and dis-
close patient information for fundraising purposes.
5
 This article is 
the first law review article to critique and propose corrections to 
provisions within the Final Regulations that expand the permis-
sible scope of uses and disclosures of protected health information 
(“PHI”)
6
 for fundraising purposes
7
 as well as related provisions 
 
 1. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notifica-
tion Rules under the Health Information Technology for Economic and Clinical Health Act 
and the Genetic Information Nondiscrimination Act; Other Modifications to the HIPAA 
Rules, 78 Fed. Reg. 5566, 5700 (Jan. 25, 2013) (to be codified at 45 C.F.R. pts. 160, 164). 
 2. Privacy of Individually Identifiable Health Information, 45 C.F.R. §§ 164.500–.534 
(2013). 
 3. The Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-
191, § 264, 110 Stat. 1936, 2033 (1996). 
 4. Id. §§ 261–70. 
 5.  U.S. DEP’T HEALTH & HUMAN SERVS., NOTICE OF PRIVACY PRACTICES 3–5 (2013) 
[hereinafter MODEL NOTICE]. 
 6. OTHER MODIFICATIONS TO THE HIPPA RULES, 78 Fed. Reg. at 5689 (defining PHI 
with reference to individually identifiable health information with certain exceptions).  
 7. Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78 
Fed. Reg. 32,466, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pts. 160, 164).  
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within the Model Notice that fail to alert patients to these ex-
panded information uses and disclosures.
8
 
This article proceeds as follows: Part I reviews the history of 
the Privacy Rule. Part II examines HHS’s regulation of the use 
and disclosure of PHI for fundraising with a focus on HHS’s pro-
gressively weakened confidentiality protections. That is, in a pro-
posed rule issued in 1999, HHS would have required prior written 
authorization from a patient before the patient’s health care pro-
viders could use or disclose the patient’s PHI for fundraising pur-
poses. In a final rule issued in 2000, HHS changed tack, allowing 
health care providers to use and disclose some limited demo-
graphic information about the patient as well as the patient’s 
dates of health care for fundraising purposes without prior writ-
ten authorization. Other information uses and disclosures still 
required prior written authorization from the patient. In early 
2013, HHS significantly expanded the classes of PHI that health 
care providers may use and disclose for fundraising without prior 
patient authorization and, in fall 2013, HHS released its Model 
Notice, which does not alert patients to these additional infor-
mation uses and disclosures. Part II of this article carefully 
charts the diminution of HHS’s confidentiality protections in the 
context of fundraising over the last fourteen years with a special 
focus on the content of public commentary provided during the 
notice-and-comment rulemaking process as well as HHS’s re-
sponse to that commentary. Part II thus focuses on the develop-
ment and current status of the law of grateful patient fundraising 
and other activities designed to increase philanthropic donations 
to hospitals and other health care institutions. 
Part III of this article examines the growing business of health 
care philanthropy. Part III explains why health care institutions 
rely so heavily on philanthropic donations, including because of 
the expense of medical equipment, inadequate Medicare and 
Medicaid reimbursement, high uncompensated health care costs, 
and rising health care compliance costs associated with health 
care reform. Part III chronicles the ways in which health care in-
stitutions attempt to increase revenue through health care phi-
lanthropy. Part III focuses in particular on one type of health care 
philanthropy known as grateful patient fundraising and details 
 
 8. See infra Part IV. 
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the ways in which hospitals and physicians identify and solicit 
grateful patients. 
Part IV of this article examines whether the Final Regulations 
properly balance an individual’s interest in maintaining health 
information confidentiality with the interest of health care pro-
viders in obtaining philanthropic donations. Concluding that the 
Final Regulations do not properly balance such interests, Part IV 
argues that prior written authorization should be sought and ob-
tained before any information other than demographic infor-
mation and dates relating to the provision of health care (collec-
tively, “demographic information”) is used or disclosed for 
fundraising purposes for four reasons. First, patients likely do not 
expect that their PHI is being used and disclosed for fundraising 
purposes in exchange for their request for and receipt of health 
care and the Model Notice does nothing to improve these patient 
expectations. Second, fundraising is neither a core function of 
covered entities nor necessary to support a core function of cov-
ered entities. Third, a fundraiser who receives and uses non-
demographic information to create a targeted fundraising com-
munication or a third party who reads a targeted fundraising 
communication could easily determine the patient’s general 
health condition or the health care services requested or received 
by the patient. Fourth, a close examination of the comments re-
ceived by HHS in response to the proposed rule that preceded the 
Final Regulations does not reveal a shift in public attitudes re-
garding the appropriate balance of health information confidenti-
ality and health care philanthropy. Rather, the comments indi-
cate that covered entities would still like to gather, use, and 
disclose as much information as possible about patients for fund-
raising purposes and that patients’ rights advocates and privacy 
coalitions still prefer to prioritize patient confidentiality. The fact 
that covered entities would still like to gather, use, and disclose 
an expanded class of PHI for fundraising does not mean that phi-
lanthropy should, on a normative level, outweigh basic patients’ 
rights. Rather, this article proposes that health information con-
fidentiality and health care philanthropy be balanced through a 
more express notification of fundraising and prior authorization 
requirement. 
Part V of this article proposes corrections to provisions within 
the Final Regulations and the Model Notice governing the use 
and disclosure of PHI for fundraising activities. That is, Part V 
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proposes a prohibition on health care providers using or disclos-
ing PHI, other than demographic information, for fundraising 
purposes without prior written notification to and authorization 
from the patient. Part V offers sample fundraising notification 
and authorization language that health care providers may in-
corporate into their informed consent conversations, notices of 
privacy practices, and authorization forms. Because the Privacy 
Rule is necessarily limited to the topic of health information con-
fidentiality, Part V also incorporates by reference a complemen-
tary set of ethical guidelines proposed in a companion article.
9
 
These guidelines address and resolve additional ethical issues 
raised by physician involvement in grateful patient fundraising. 
I.  THE PRIVACY RULE: A BRIEF HISTORY 
As signed into law by President Clinton on August 21, 1996, 
HIPAA had several purposes, including improving portability and 
continuity of health insurance coverage in individual and group 
markets, combating health care fraud and abuse, promoting the 
use of medical savings accounts, improving access to long-term 
care services and insurance coverage, and simplifying the admin-
istration of health insurance.
10
 The administrative simplification 
provisions, codified at Subtitle F of Title II of HIPAA, directed 
HHS to issue regulations protecting the privacy
11
 of individually 
 
 9. See Stacey A. Tovino, Giving Thanks: The Ethics of Grateful Patient Fundraising, 
103 KY. L.J. (forthcoming 2015) [hereinafter Tovino, Giving Thanks]. 
 10. The Health Insurance Portability and Accountability Act of 1996, Pub. L. No. 104-
191, 110 Stat. 1936 (1996).  
 11. Id. § 264(c), 110 Stat. at 2033. Elsewhere, I defined and distinguished the concepts 
of privacy and confidentiality in the context of advances in functional magnetic resonance 
imaging. Stacey A. Tovino, Functional Neuroimaging Information: A Case for Neuro Ex-
ceptionalism?, 34 FLA. ST. U. L. REV. 415, 441–42 (2007) [hereinafter Tovino, Functional 
Neuroimaging Information]. This article uses these same basic definitions and distinc-
tions. That is, in the health care context, “privacy” includes a patient’s interest in avoiding 
the unwanted collection by a third party of health or other information about the patient. 
Id. at 442. On the other hand, “confidentiality” refers to the obligation of a health industry 
participant to prevent the unauthorized or otherwise inappropriate use or disclosure of 
voluntarily given and appropriately gathered health and other information relating to a 
patient. Id. The terms “privacy” and “confidentiality” are frequently confused. Indeed, the 
Privacy Rule is actually a health information confidentiality rule because it sets limits on 
how health care providers and other covered entities can use and disclose appropriately 
gathered PHI. Id. at 449. However, I do use the term “Privacy Rule” in this article because 
that is the name given by HHS and used by the public for the rule. See, e.g., HIPAA and 
the Privacy Rule, PARTNERS HEALTH CARE, https://healthcare.partners.org/phsirb/hrchi 
paa.htm (last visited Apr. 14. 2014); The Privacy Rule, U.S. DEP’T HEALTH & HUMAN 
SERVS., http://www.hhs.gov/ocr/privacy/hipaa/administrative/privacyrule/index.html (last 
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identifiable health information if Congress failed to enact com-
prehensive privacy legislation within three years of HIPAA’s en-
actment.
12
 When Congress failed to enact privacy legislation by its 
deadline, HHS incurred the duty to adopt privacy regulations.
13
 
The original HIPAA statute clarified, however, that any privacy 
regulations adopted by HHS must be made applicable only to 
three classes of individuals and institutions: (1) health plans; (2) 
health care clearinghouses; and (3) health care providers who 
transmit health information in electronic form in connection with 
certain standard transactions (each, a “covered entity”; collective-
ly, “covered entities”).
14
 
HHS responded. On November 3, 1999,
15
 and December 28, 
2000, HHS issued a proposed and final Privacy Rule regulating 
covered entities’ uses and disclosures of, and requests for, PHI.
16
 
On March 27, 2002,
17
 and August 14, 2002, HHS issued proposed 
and final modifications to the Privacy Rule.
18
 With the exception 
of technical corrections and conforming amendments,
19
 these 
rules as reconciled remained largely unchanged between 2002 
and 2009. 
 
visited Apr. 14, 2014). 
 12. § 264(c), 110 Stat. at 2033 (“If legislation governing standards with respect to the 
privacy of individually identifiable health information . . . is not enacted by the date that 
is 36 months after the date of the enactment of this Act, the Secretary of Health and Hu-
man Services shall promulgate final regulations containing such standards . . . .”). 
 13. See id. 
 14. Id. § 1172(a), 110 Stat. at 2023. See generally Standards for Privacy of Individual-
ly Identifiable Health Information, 64 Fed. Reg. 59,918, 59,924 (proposed Nov. 3, 1999) (to 
be codified at 45 C.F.R. pts. 160–64) (explaining that HHS did not directly regulate any 
entity that was not a covered entity because it did not have the statutory authority to do 
so). 
 15. Standards for Privacy of Individually Identifiable Health Information, 64 Fed. 
Reg. at 59,918. 
 16. Standards for Privacy of Individually Identifiable Health Information, 65 Fed. 
Reg. 82,462 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164). 
 17. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. 
Reg. 14,776 (proposed Mar. 27, 2002) (to be codified at 45 C.F.R. pts. 160, 164). 
 18. Standards for Privacy of Individually Identifiable Health Information, 67 Fed. 
Reg. 53,182 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160, 164). 
 19. See, e.g., Standards for Privacy of Individually Identifiable Health Information, 
Final Rule; Correction of Effective and Compliance Dates, 66 Fed. Reg. 12,434 (Feb. 26, 
2001) (to be codified at 45 C.F.R. pts. 160, 164); Technical Corrections to the Standards for 
Privacy of Individually Identifiable Health Information Published December 28, 2000, 65 
Fed. Reg. 82,944 (Dec. 29, 2000) (to be codified at 45 C.F.R. pts. 160, 164). 
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The nature and scope of the legal duties of confidentiality that 
applied to covered entities and their business associates (“BAs”)
20
 
changed significantly over four years ago. On February 17, 2009, 
President Obama signed the American Recovery and Reinvest-
ment Act (“ARRA”) into law.
21
 Division A, Title XIII of ARRA, bet-
ter known as the Health Information Technology for Economic 
and Clinical Health Act (“HITECH”), contained certain provisions 
that required HHS to modify some of the information use and dis-
closure requirements and definitions set forth in the Privacy Rule 
as well as the amount of civil penalties that may be imposed on 
covered entities and BAs who violate the Privacy Rule.
22
 
Since ARRA’s enactment, HHS has been busy issuing proposed 
rules, interim final rules, final rules, and technical corrections 
that implement HITECH’s required changes to the Privacy Rule. 
On August 24, 2009, HHS released an interim final rule imple-
menting HITECH’s new breach notification requirements.
23
 On 
October 30, 2009, HHS released an interim final rule implement-
ing HITECH’s strengthened enforcement provisions, including 
strengthened civil monetary penalties that the federal Office for 
Civil Rights may, for the first time since the enactment of the 
HIPAA statute, impose directly on BAs who fail to maintain the 
 
 20. Business associates are defined to include individuals and institutions who: (1) on 
behalf of a covered entity, but other than in the capacity of a member of the workforce of a 
covered entity, create, receive, maintain, or transmit PHI for a function or activity regu-
lated by the HIPAA Privacy Rule, and (2) provide, other than in the capacity of a member 
of the workforce of such covered entity, legal, actuarial, accounting, consulting, data ag-
gregation, management, administrative, accreditation, or financial services to or for the 
covered entity. See Modifications to the HIPAA Privacy, Security, Enforcement, and 
Breach Notification Rules under the Health Information Technology for Economic and 
Clinical Health Act and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 
5566, 5688 (Jan. 25, 2013) (to be codified at 45 C.F.R. pts. 160, 164). 
 21. American Recovery and Reinvestment Act of 2009, Pub. L. No. 111-5, 123 Stat. 
115 (2009). 
 22. Health Information Technology for Economic and Clinical Health Act, Pub. L. No. 
111-5, § 3001, 123 Stat. 115, 226–32 (2009). Elsewhere, I critiqued HITECH’s imposition 
of confidentiality requirements directly on BAs and I proposed statutory and regulatory 
changes to HITECH and the HIPAA Privacy Rule, respectively, that would except a class 
of BAs, including outside counsel, from the confidentiality obligations imposed on other 
BAs. See Stacey A. Tovino, Gone Too Far: Federal Regulation of Health Care Attorneys, 91 
OR. L. REV. 813 (2013) [hereinafter Tovino, Gone Too Far]. This article builds on my earli-
er work by further critiquing the Final Regulations in an additional context; that is, in the 
context of hospitals that wish to use and disclose PHI to raise funds for their own benefit. 
 23. Breach Notification for Unsecured Protected Health Information, 74 Fed. Reg. 
42,740, 42,740 (Aug. 24, 2009) (to be codified at 45 C.F.R. pts. 160, 164); Macon Phillips, 
Signed, Sealed, Delivered: ARRA, WHITE HOUSE BLOG (Feb. 17, 2009, 4:25 PM), http:// 
www.whitehouse.gov/blog/09/02/17/signed-sealed-delivered-ARRA. 
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confidentiality of PHI.
24
 On July 14, 2010, HHS released a pro-
posed rule that would modify the HIPAA Privacy, Security, 
Breach Notification, and Enforcement Rules in accordance with 
HITECH.
25
 On May 31, 2011, HHS released a proposed rule that 
would modify the HIPAA Privacy Rule’s accounting of disclosures 
requirement.
26
 On September 14, 2011, HHS released a proposed 
rule that would modify the Privacy Rule to provide individuals 
with the right to receive their laboratory test reports directly 
from their testing laboratories.
27
 On January 25, 2013, HHS re-
leased the Final Regulations, which modify the HIPAA Privacy, 
Security, Breach Notification, and Enforcement Rules in accord-
ance with HITECH.
28
 On June 7, 2013, HHS released technical 
corrections to the Final Regulations.
29
 Finally, on September 16, 
2013, HHS released the Model Notice designed to assist covered 
entities in complying with the Final Regulations.
30
 This article 
critiques and proposes further corrections to the fundraising pro-
visions that were set forth in the January 25, 2013 rulemaking, 
and technically corrected on June 7, 2013,
31
 as well as related 
fundraising provisions within the Model Notice. 
The critiques and proposals set forth in this article are illustra-
tive rather than exhaustive. I disagree with many of the changes 
set forth in the Final Regulations and this article is but one in-
stallment in a series of articles criticizing the Final Regulations. 
Elsewhere, I critiqued HITECH’s imposition of confidentiality re-
 
 24. HIPAA Administrative Simplification: Enforcement, 74 Fed. Reg. 56,123, 56,123  
(Oct. 30, 2009) (to be codified at 45 C.F.R. pts. 160, 164). 
 25. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the 
Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 40,868 
(proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164). 
 26. HIPPA Privacy Rule Accounting of Disclosures Under the Health Information 
Technology for Economic and Clinical Health Act, 76 Fed. Reg. 31,426, 31,426 (proposed 
May 31, 2011) (to be codified at 45 C.F.R. pt. 164). 
 27. CLIA Program and HIPAA Privacy Rule; Patients’ Access to Test Reports, 76 Fed. 
Reg. 56,712, 56,712 (proposed Sept. 14, 2011) (to be codified at 45 C.F.R. pt. 164). 
 28. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notifica-
tion Rules under the Health Information Technology for Economic and Clinical Health Act 
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 5566, 5566 (Jan. 25, 
2013) (to be codified at 45 C.F.R. pts. 160, 164). 
 29. Technical Corrections to the HIPAA Privacy, Security, and Enforcement Rules, 78 
Fed. Reg. 32,466, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pts. 160, 164). 
 30. MODEL NOTICE, supra note 5. 
 31. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notifica-
tion Rules under the Health Information Technology for Economic and Clinical Health Act 
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. at 5566; Technical Cor-
rections to the HIPAA Privacy, Security, and Enforcement Rules, 78 Fed. Reg. at 32,466. 
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quirements directly on BAs and proposed a correction that would 
except certain classes of BAs that are already regulated with re-
spect to their use and disclosure of confidential client infor-
mation, including state-licensed attorneys who are subject to 
state bar disciplinary action for the misuse of confidential client 
information.
32
 In addition, on May 31, 2011, HHS released a pro-
posed rule that would modify the Privacy Rule’s accounting of 
disclosures requirement to include an access report requirement.
33
 
If HHS adopts the access report requirement in final regulations, 
I will make an administrative law critique of those final regula-
tions as well. This article is well situated between my completed 
article and my anticipated article as it has a specific and detailed 
goal; that is, to properly balance a patient’s interest in maintain-
ing the confidentiality of his or her health information with the 
interest of a health care provider in using and disclosing the pa-
tient’s PHI to raise funds for the provider’s own benefit. 
Before proceeding towards this goal, a brief summary of the 
Privacy Rule’s theory and approach to health information confi-
dentiality is necessary. The Privacy Rule has as its goal the bal-
ancing of the interest of individuals in maintaining the confiden-
tiality of their health information and the interest of society in 
obtaining, using, and disclosing health information to carry out a 
variety of public and private activities.
34
 To that end, the Privacy 
Rule regulates covered entities’ and BAs’ uses of, disclosures of, 
and requests for individually identifiable health information
35
 to 
 
 32. See Tovino, Gone Too Far, supra note 22, at 814–67. 
 33. HIPAA Privacy Rule Accounting of Disclosures Under the Health Information 
Technology for Economic and Clinical Health Act, 76 Fed. Reg. 31,426, 31,429 (proposed 
May 31, 2011) (to be codified at 45 C.F.R. pt. 164). 
 34. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. 
Reg. 82,462, 82,464 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) (“The rule 
seeks to balance the needs of the individual with the needs of the society.”); id. at 82,468 
(“The task of society and its government is to create a balance in which the individual’s 
needs and rights are balanced against the needs and rights of society as a whole.”); id. at 
82,472 (“The need to balance these competing interests—the necessity of protecting priva-
cy and the public interest in using identifiable health information for vital public and pri-
vate purposes—in a way that is also workable for the varied stakeholders causes much of 
the complexity in the rule.”). 
 35. “Individually identifiable health information” is defined as  
information that is a subset of health information, including demographic in-
formation collected from an individual, and: (1) [i]s created or received by a 
health care provider, health plan, employer, or health care clearinghouse; 
and (2) [r]elates to the past, present, or future physical or mental health or 
condition of an individual; the provision of health care to an individual; or the 
past, present, or future payment for the provision of health care to an indi-
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the extent such information does not constitute: (1) an education 
record protected under the Family Educational Rights and Priva-
cy Act of 1974 (“FERPA”); (2) a student treatment record excepted 
from protection under FERPA; (3) an employment record held by 
a covered entity in its role as an employer; or (4) individually 
identifiable health information regarding a person who has been 
deceased for more than fifty years.
36
 The name given by the Pri-
vacy Rule to the subset of individually identifiable health infor-
mation described in the previous sentence is PHI.
37
 
The Privacy Rule requires covered entities to adhere to three 
different levels of patient permission when using or disclosing 
PHI for different activities.
38
 Again, the varying levels of patient 
permission reflect HHS’s desire to appropriately balance the in-
terest of individuals in maintaining the confidentiality of their 
health information with a wide range of societal interests in ob-
taining, using, and disclosing PHI.
39
 A review of the three levels of 
patient permission is necessary before discussing the level of pa-
tient permission that is appropriate for fundraising. 
The first level of patient permission is actually no patient per-
mission at all. That is, covered entities may freely use and dis-
close PHI without any form of prior patient permission for their 
own treatment,
40
 payment,
41
 and health care operations activi-
ties,
42
  as well as certain public policy activities.
43
 For example, a 
 
vidual; and (i) [t]hat identifies the individual; or (ii) [w]ith respect to which 
there is a reasonable basis to believe the information can be used to identify 
the individual. 
Privacy of Individually Identifiable Health Information, 45 C.F.R. § 160.103 (2013). 
 36. Id. (defining “protected health information”). 
 37. Id. (using the name “protected health information”). 
 38. Id. §§ 164.502–.514 (setting forth the use and disclosure requirements). 
 39. See supra text accompanying note 34. 
 40. “Treatment” is defined as  
the provision, coordination, or management of health care and related ser-
vices by one or more health care providers, including the coordination or 
management of health care by a health care provider with a third party; con-
sultation between health care providers relating to a patient; or the referral 
of a patient for health care from one health care provider to another. 
45 C.F.R. § 164.501. 
 41. “Payment” is defined as the “activities undertaken by . . . a health plan to obtain 
premiums or to determine or fulfill its responsibility for coverage and provision of benefits 
under the health plan” as well as the activities of a “health care provider or health plan to 
obtain or provide reimbursement for the provision of health care.” Id. 
 42. “Health care operations” is defined with respect to a list of activities that are re-
lated to a covered entity’s covered functions. Id. These activities include, but are not lim-
ited to, conducting quality assessment and improvement activities, conducting training 
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covered general practitioner who wishes to consult with a special-
ist may disclose PHI to the specialist in order to allow the general 
practitioner to treat the patient and the Privacy Rule does not re-
quire the patient to give his or her prior authorization.
44
 Likewise, 
a covered hospital that treats a patient may send a bill to the pa-
tient’s insurer to obtain payment for hospital services rendered.
45
 
Again, the billing may occur without the patient’s prior authori-
zation.
46
 Similarly, a teaching physician employed by a covered 
academic medical center may involve medical students in patient 
care, without patient authorization, to enable the students to 
learn to practice medicine while under physician supervision.
47
 A 
covered entity that is required by state or other law to disclose 
PHI to another individual or entity may do so without patient au-
thorization.
48
 By final illustrative, but not exhaustive, example, a 
covered entity may disclose a patient’s PHI to a law enforcement 
officer in certain situations, including when the covered entity 
suspects that the death of the patient may have resulted from 
criminal conduct.
49
 The theory behind these permissions is that 
treating patients, allowing health care providers to obtain reim-
bursement for health care services rendered, training medical 
students, complying with state law, and alerting law enforcement 
officers to the suspicion of criminal activity outweigh a patient’s 
interest in maintaining complete confidentiality. 
 
programs in which medical and other health care students learn to practice health care 
under supervision, and arranging for the provision of legal services. Id.; see id. § 
164.506(c)(1) (permitting a covered entity to use or disclose PHI for its own treatment, 
payment, or health care operations). 
 43. Covered entities may use and disclose PHI for twelve different public policy activi-
ties without the prior written authorization of the individual who is the subject of the in-
formation. Id. § 164.512(a)–(l). These public policy activities include, but are not limited 
to, uses and disclosures required by law, uses and disclosures for public health activities, 
disclosures for law enforcement activities, uses and disclosures for research, and disclo-
sures for workers’ compensation activities. Id. § 164.512(a), (c), (f), (i), (l). 
 44. Id. § 164.501 (defining treatment to include “consultations between health care 
providers relating to a patient”). 
 45. Id. (defining payment to include “the activities undertaken by [a] health care pro-
vider . . . to obtain . . . reimbursement for the provision of health care”). 
 46. Id. § 164.506(c)(1) (permitting a covered entity to disclose PHI for its own payment 
activities). 
 47. Id. § 164.501 (defining health care operations to include “conducting training pro-
grams in which students, trainees, or practitioners in areas of health care learn under su-
pervision to practice or improve their skills as health care providers”). 
 48. Id. § 164.512(a)(1) (allowing covered entities to “use or disclose protected health 
information to the extent that such use or disclosure is required by law and the use or dis-
closure complies with and is limited to the relevant requirements of such law”). 
 49. Id. § 164.512(f)(4). 
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Under the second level of patient permission, a covered entity 
may use and disclose a patient’s PHI for certain activities, but on-
ly if the individual is informed in advance of the use or disclosure 
and has the opportunity to agree to or prohibit or restrict the use 
or disclosure.
50
 Because the Privacy Rule allows the covered entity 
to orally inform the individual of (and capture an oral agreement 
or oral objection to) a use or disclosure permitted by these provi-
sions, this level of patient permission is sometimes referred to as 
the “oral permission” level, although a more practical written 
permission also will suffice. Under the Privacy Rule, a covered 
entity can conduct five sets of information uses and disclosures 
once the individual who is the subject of the information has been 
notified and has either agreed or not objected to the information 
use or disclosure.
51
 These five sets of information uses and disclo-
sures include certain uses and disclosures of directory infor-
mation, such as name, location, general condition, and religious 
affiliation;
52
 certain uses and disclosures that would allow other 
persons to be involved in a patient’s care or payment for care;
53
 
certain uses and disclosures that would help notify, or assist in 
the notification of, family members, personal representatives, and 
other persons responsible for the care of the individual of the in-
dividual’s location, general condition, or death;
54
 certain uses and 
disclosures for disaster relief purposes;
55
 and certain disclosures 
to family members and other persons who were involved in the 
individual’s care or payment for health care prior to the individu-
al’s death of PHI that is relevant to that person’s involvement.
56
 
Under this second level of patient permission, the hospital 
room number and the general condition of a patient (e.g., “good,” 
“fair,” “poor,” “stable”) who has given her permission or who has 
not expressed an objection may be disclosed to a visitor who wish-
es to visit an identifiable patient in the hospital.
57
 Likewise, a 
woman in labor who wishes her partner to be present for her la-
bor and delivery may orally give permission for her health care 
 
 50. Id. § 164.510. 
 51. Id. § 164.510(a)(1). 
 52. Id. § 164.510(a)(1)(i)(A)–(D). 
 53. Id. § 164.510(b)(1)(i). 
 54. Id. § 164.510(b)(1)(ii). 
 55. Id. § 164.510(b)(4). 
 56. Id. § 164.510(b)(5). 
 57. Id. § 164.510(a)(1)–(2). 
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providers to involve her partner in her care.
58
 The theory behind 
requiring oral permission for these information uses and disclo-
sures is that the patient has an interest in maintaining the confi-
dentiality of her health information; however, the patient also 
may have an interest in being visited in the hospital, in obtaining 
assistance with the patient’s health care or payment for health 
care, and being assisted during a disaster. In addition, the pa-
tient’s family may have an interest in visiting the patient in the 
hospital, assisting the patient with his or her health care and fi-
nancial needs, and obtaining assistance during a disaster. The 
required oral permission reflects the patient’s interest in main-
taining the confidentiality of his or her health information, but 
the lack of a requirement for a formal written authorization re-
flects HHS’s desire to make it easy for the patient to ask for or 
agree to receive help. 
The third (and highest) level of patient permission is prior 
written authorization. In the event that a covered entity would 
like to use or disclose PHI for a purpose that is not treatment, 
payment, or health care operations, that does not fall within one 
of the twelve public policy exceptions, that is not allowed with 
oral permission, and that is not otherwise permitted or required 
by the Privacy Rule, the covered entity must obtain the prior 
written authorization of the individual who is the subject of the 
information.
59
 The Privacy Rule specifies the form of the authori-
zation, including certain required elements and statements that 
are designed to place the individual on notice of how the individ-
ual’s PHI will be used or disclosed.
60
 This high level of patient 
permission reflects the value HHS places on a patient’s interest 
in maintaining the confidentiality of her health information com-
pared to other societal interests that are far removed from the 
core functions of covered entities, such as a health care provider’s 
interest in selling the patient’s information to a tabloid magazine 
or a health plan’s interest in disclosing the patient’s information 
to a marketing company to allow the company to market its prod-
ucts and services to the patient.
61
 
 
 58. Id. § 164.510(b)(1)(i). 
 59. Id. § 164.508(a)(1). 
 60. Id. § 164.508(c)(1)–(2). 
 61. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. 
Reg. 82,462, 82,514 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) (“[C]overed 
entities must obtain the individual’s authorization before using or disclosing protected 
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With this background, Part II of this article examines the his-
tory of HHS’s regulation of the use and disclosure of PHI for 
fundraising purposes and identifies HHS’s current placement of 
fundraising activities within these three levels of patient permis-
sion. As discussed in more detail in Parts IV and V, this article 
proposes that HHS move almost all fundraising activities from 
the first tier to the third tier of patient permission. 
II.  THE REGULATION OF THE USE AND DISCLOSURE OF PHI FOR 
FUNDRAISING 
Again, imagine a covered entity that would like to use or dis-
close a patient’s PHI in order to raise funds for the covered enti-
ty’s own benefit. For example, a general acute care hospital affili-
ated with a major academic medical center would like to embark 
on a capital campaign to raise funds to expand the infrastructure 
of, and technological and human resources available through, the 
hospital’s medical, surgical, and radiation oncology departments. 
To raise funds, the hospital’s major gifts officer would like to ac-
cess health information in its electronic patient database to select 
patients who have received medical, surgical, or radiation oncolo-
gy services, who had favorable health outcomes, and who live in 
certain zip codes known to be associated with a high median 
family income, or who have other indicators that suggest wealth.
62
 
The gifts officer believes that these patients, given their positive 
health care experiences, may be inclined to donate money to the 
hospital,
63
 and may have the discretionary funds to do so. These 
types of patients are referred to as “grateful patients” and the so-
licitation of funds from grateful patients is frequently referred to 
 
health information for marketing purposes.”). 
 62. See GRENZEBACH, GLIER & ASSOCS., GRATEFUL PATIENTS: CRITICAL SUCCESS 
FACTORS FOR NAVIGATING HEALTHCARE’S FASTEST GROWING DONOR SEGMENT 3 (2013) 
[hereinafter GRATEFUL PATIENTS], available at http://www.donorscape.com/assets/files/ 
Grateful%20Patient%20White%20Paper%20202013.pdf (providing health care fundraising 
advice and noting that “City or Zip code is a common method for segmenting large files, 
since, clearly, there are correlations between geographic areas and relative wealth”). 
 63. See generally After ARRA, CEs Should Tighten Compliance with Fundraising 
Rules, ASS’N FOR HEALTHCARE PHILANTHROPY (May 7, 2009), http://sharepoint.ahp.org/ 
publicationandtools/News/IntheNew/AHPInNews_2009/Pages/AfterARR.aspx?PF=1 [here-
inafter AHP, After ARRA] (noting that individuals who have received life-saving treat-
ments and are grateful for such treatments are referred to as “grateful patients” and, “his-
torically, [they are] the highest givers”). 
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as “grateful patient fundraising” or “grateful patient philanthro-
py.”
64
 
After searching its electronic patient database, the gifts officer 
identifies the woman described in the opening paragraph of this 
article; that is, the forty-year-old woman who had been diagnosed 
with stage IV colorectal cancer five years ago, who was given less 
than a ten percent chance of living five years, and who, five years 
later, is healthy and disease free after a rigorous combination of 
surgery, radiation, and chemotherapy. 
If the woman’s address is associated with an affluent part of 
town, or if other demographic indicators or publicly available da-
ta
65
 reveal actual or probable wealth, the gifts officer may ask the 
woman’s treating physician to initiate a private conversation with 
the woman regarding the hospital’s health care philanthropy 
needs during one of the woman’s follow-up appointments. If the 
woman’s address or other publicly available data suggests mid-
dle- to upper-middle class, but not wealthy, status, the major gifts 
officer may wish to disclose the woman’s home address to a con-
tracted commercial fundraiser, who will send the woman a letter 
requesting a monetary donation that would be used to expand the 
 
 64. Grateful Patients Build, NONPROFIT TIMES (Sept. 15, 2009), http://www.the non-
profittimes.com/news-articles/grateful-patients-build/ (explaining that grateful patients 
and their families are typically the largest donor base for healthcare philanthropy); Lind-
sey Getz, In Tight Economic Times, Former Patients Become the Focus of Fundraising, 
HOSP. & HEALTH NETWORK MAG., Nov. 2008, at 12 (noting that since 2003, forty percent of 
major gifts received by the University of Kansas Hospital have come from grateful pa-
tients or their families); see, e.g., Scott M. Wright et al., Ethical Concerns Related to Grate-
ful Patient Philanthropy: The Physician’s Perspective, 28 J. GEN. INTERNAL MED. 645, 645 
(2012) (“Philanthropy is a vital source of financial support for academic medical centers, 
and grateful patients may be the single most important source for substantive philan-
thropic gifts.”); Page Bullington, First Steps for Successful Grateful Patient Fundraising, 
TARGET ANALYTICS, Apr. 2011, at 1, available at http://www.blackbaud.com/files/ resources 
/downloads/WhitePaper_FirstStepsForSuccessfulGratefulPatientFundraising.pdf (“For 
any healthcare institution, an excellent source of new donors can be grateful patients. 
Programs that reach out to these individuals can form the cornerstones of successful 
healthcare fundraising operations.”); Dan Lowman, SENIOR VICE PRESIDENT, GRENZEBACH 
GLIER & ASSOCS., Successful Grateful Patient Fundraising Programs: Practical Steps for 
Tapping the Fastest Growing Donor Segment in Healthcare (July 1, 2010), available at 
http://www.grenzebachglier.com/assets/files/webinars/GG+A%20Webinar%20-%20success 
ful%20Grateful%20Patient%20programs%20-%207.1.10.pdf (explaining why grateful pa-
tients give more money than do corporations and foundations). 
 65. See Steven Rum & Scott M. Wright, A Randomized Trial to Evaluate Methodolo-
gies for Engaging Academic Physicians in Grateful Patient Fundraising, 87 ACAD. MED. 
55, 57 (2012) (listing wealth indicators (including annual income, real estate assets, direct 
stock holdings, pension plan value, and investment data estimations) that may be pulled 
or estimated from publicly available sources). 
TOVINO 484 (DO NOT DELETE) 4/18/2014  9:12 AM 
1172 UNIVERSITY OF RICHMOND LAW REVIEW [Vol. 48:1157 
resources available to future patients through the hospital’s on-
cology department. If the woman is a Medicaid beneficiary, eligi-
bility for which is tied to low-income and low resources, the hospi-
tal may wish to spend no time or resources requesting monetary 
donations from the woman. 
Although the woman described in the preceding paragraphs is 
fictitious, there are many examples of actual grateful patients 
who have made significant donations to their hospitals and other 
health care providers. One well-known example is Annette Bloch, 
wife of H&R Block co-owner Richard Bloch.
66
 The Bloch Cancer 
Foundation donated $20 million to a hospital affiliated with the 
University of Kansas after Annette received treatment for her 
breast cancer there.
67
 
Our hypothetical does raise several legal issues, however. One 
legal issue is whether a treating physician may initiate a private 
conversation with the woman regarding the hospital’s health care 
philanthropy needs during one of the woman’s follow-up ap-
pointments. Since its inception, the Privacy Rule has allowed 
physicians to converse with patients regarding a range of activi-
ties without the patient’s prior written authorization or other in-
dication of interest in the activity. For example, the Privacy Rule 
allows physicians who conduct clinical research to contact their 
patients for purposes of making them aware of clinical trials in 
which the patients may wish to participate, even without any pri-
or written authorization or other indication from such patients 
that they are interested in participating in research.
68
 HHS rea-
sons that a physician who contacts a patient for purposes of mak-
ing the patient aware of a clinical trial relevant to the patient’s 
illness is engaged in “treatment” activities that fall within the 
first level of patient permission discussed in Part I of this arti-
 
 66. Annette Bloch: Advocate, Philanthropist, Survivor, UNIV. OF KAN. CANCER CTR., 
http://www.kucancercenter.org/surviving-cancer/patient-stories/annette-bloch-story (last 
visited Apr. 14, 2014). 
 67. Getz, supra note 64, at 12 (describing the donation made by the R.A. Bloch Cancer 
Foundation to the University of Kansas Hospital). 
 68. U.S. DEP’T HEALTH & HUMAN SERVS., CLINICAL RESEARCH AND THE HIPAA 
PRIVACY RULE 4 (2004), available at http://privacyruleandresearch.nih.gov/pdf/clin_resear 
ch.pdf (“To contact potential study participants, a researcher may do so, without Authori-
zation from the individual, under the following circumstances: . . . [A] covered health care 
provider may discuss treatment alternatives, which may include participating in a clinical 
trial, with the patient as part of the patient’s treatment or the covered entity’s health care 
operations.”). 
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cle.
69
 Therefore, the Privacy Rule requires no prior written au-
thorization or other indication of interest from the patient.
70
 
The Privacy Rule also allows physicians to initiate private face-
to-face conversations with patients regarding available health-
related and non-health related products and services without any 
authorization or other indication that the patient may be inter-
ested in purchasing or acquiring such products or services.
71
 HHS 
reasons that the Privacy Rule was not intended to police private 
communications between physicians and patients.
72
 HHS also 
reasons that patients who do not want products and services 
marketed to them can simply respond that they are uninterested 
during the face-to-face conversation.
73
 
The same general rule applies to fundraising. That is, the Pri-
vacy Rule does not prohibit a physician from initiating a private, 
face-to-face conversation with a patient regarding the hospital’s 
 
 69. See id. 
 70. See id. 
 71. See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 
164.508(a)(3)(i)(A) (2013) (“[A] covered entity must obtain an authorization for any use or 
disclosure of protected health information for marketing, except if the communication is in 
the form of . . . [a] face-to-face communication made by a covered entity to an individu-
al . . . .”); see also Standards for Privacy of Individually Identifiable Health Information, 65 
Fed. Reg. 82,462, 82,545 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) 
(“First . . . [the Privacy Rule] permits a covered entity to use or disclose protected health 
information without individual authorization to make a marketing communication if the 
communication occurs in a face-to-face encounter with the individual. This provision 
would permit a covered entity to discuss any services and products, including those of a 
third-party, without restriction during a face-to-face communication. A covered entity also 
could give the individual sample products or other information in this setting.”). 
 72. See Standards for Privacy of Individually Identifiable Health Information, 67 Fed. 
Reg. 53,182, 53,190 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160, 164) (“The De-
partment does not intend to police communications between doctors and patients that take 
place in the doctor’s office.”). 
 73. See id. (“In [the face-to-face] context, the individual can readily stop any unwanted 
communications, including any communications that may otherwise meet the definition of 
‘marketing.’”); see also Frequently Asked Questions, U.S. DEP’T HEALTH & HUMAN SERVS., 
http://www.hhs.gov/ocr/privacy/hipaa/faq/marketing/289.html (last updated Mar. 14, 2006) 
(asking, “Are health care providers required to seek a prior authorization before discussing 
a product or service with a patient, or giving a product or service to a patient, in a face-to-
face encounter?” and answering, “No. In face-to-face encounters, the HIPAA Privacy Rule 
allows covered entities to give or discuss products or services, even when not health-
related, to patients without a prior authorization. This exception prevents unnecessary 
intrusion into the doctor-patient relationship”); id. (asking, “When is an authorization re-
quired from the patient before a provider or health plan engages in marketing to that in-
dividual?” and answering, “The HIPAA Privacy Rule expressly requires an authorization 
for uses or disclosures of protected health information for ALL marketing communications, 
except in two circumstances: 1. When the communication occurs in a face-to-face encoun-
ter between the covered entity and the individual . . . .”). 
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health care philanthropy needs. The Privacy Rule also would not 
prohibit a physician in that same setting from directly asking a 
patient for a donation that would benefit the hospital. As a prac-
tical matter, no confidentiality concerns are raised because no 
other person would be present for the conversation. 
Thus, in our hypothetical, the Privacy Rule as it is currently 
written would not prohibit the oncologist from initiating a private 
conversation with the woman regarding the hospital’s health care 
philanthropy needs during one of the woman’s follow-up ap-
pointments. Again, HHS believes that the Privacy Rule was not 
designed to interfere with private communications between phy-
sicians and their patients.
74
 Although I agree that private, face-to-
face conversations do not raise confidentiality issues because no 
other person is present for the conversation, I argue in a compan-
ion article that significant physician involvement in grateful pa-
tient fundraising can risk conflicted physician decision making, 
health care resource allocation injustices, financial exploitation, 
and breach of privacy.
75
 I manage these concerns by proposing in 
that companion article ethical guidelines governing physician in-
volvement in grateful patient fundraising.
76
 
A second legal issue relates to situations in which PHI would 
be used or disclosed for fundraising activities beyond a private, 
face-to-face, physician-patient conversation. For example, many 
hospitals also would like their employed, affiliated, or contracted 
development officers, major gift officers, institutionally-related 
foundation officers, and business associates to be able to use or 
disclose PHI in order to call patients on the telephone or mail let-
ters to patients requesting donations. To select the patients who 
would receive telephone calls or mailed letters, many hospitals 
(and their affiliates and contractors) would like the ability to 
search electronic patient databases by certain criteria, such as 
treating physician, department of service, health outcome, and 
zip code, to try to identify grateful patients who have the finan-
cial ability to give. HHS has gone back and forth in proposed and 
final regulations over the past fourteen years regarding what, if 
any, information may be used by health care providers and their 
employed, affiliated, and contracted fundraisers to target patients 
 
 74. See supra notes 72–73 and accompanying text. 
 75. See Tovino, Giving Thanks, supra note 9. 
 76. Id. 
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for receipt of fundraising communications. This article argues 
that HHS’s current position, which allows sensitive PHI to be 
used and disclosed without prior patient authorization for fund-
raising purposes, insufficiently protects patient confidentiality. 
A.  The 1999 Proposed Rule 
In its first proposed Privacy Rule, published on November 3, 
1999 (“1999 Proposed Rule”), HHS would have required covered 
health care providers to obtain a patient’s formal written authori-
zation before using or disclosing any of the patient’s PHI for 
fundraising: “Uses and disclosures of protected health infor-
mation for which individual authorization is required include, but 
are not limited to, the following . . . [u]se or disclosure for fund-
raising purposes.”
77
 HHS explained in the preamble to the 1999 
Proposed Rule that fundraising was sufficiently unrelated to 
treatment and payment, the core functions of hospitals and other 
covered entities, and therefore prior patient authorization should 
be required.
78
 
B.  The 2000 Final Rule 
Over a year later, on December 28, 2000, HHS issued its first 
final Privacy Rule (“2000 Final Rule”) and changed its approach 
to fundraising.
79
 The 2000 Final Rule allowed covered entities to 
internally use and externally disclose to BAs and institutionally 
related foundations certain classes of PHI for fundraising purpos-
 
 77. See Standards for Privacy of Individually Identifiable Health Information, 64 Fed. 
Reg. 59,918, 60,055 (proposed Nov. 3, 1999) (to be codified at 45 C.F.R. pts. 160–64); see 
also Mary Chris Jaklevic, Another Battle: HIPAA Threatens Doc Referrals in Soliciting 
Donations, MOD. HEALTHCARE, May 6, 2002, at 14 [hereinafter Jaklevic, Another Battle] 
(“A stricter version of the regulations proffered by the Clinton administration and opposed 
by the industry would have forbidden hospitals from using patient data for fund raising.”). 
 78. See Standards for Privacy of Individually Identifiable Health Information, 64 Fed. 
Reg. at 59,941 (“[W]e determined that it would be helpful to identify activities that, in our 
opinion, are sufficiently unrelated to the treatment and payment functions to require a 
[sic] individual to authorize use of his or her information. We want to make clear that 
these activities would not be prohibited, and do not dispute that many of these activities 
are indeed beneficial to both individuals and the institutions involved. Nonetheless, they 
are not necessary for the key functions of treatment and payment and therefore would re-
quire the authorization of the individual before his/her information could be used. These 
activities would include but would not be limited to: . . . The use or disclosure of infor-
mation for fund raising purposes.”). 
 79. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. 
Reg. 82,462 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164). 
TOVINO 484 (DO NOT DELETE) 4/18/2014  9:12 AM 
1176 UNIVERSITY OF RICHMOND LAW REVIEW [Vol. 48:1157 
es without prior authorization.
80
 That is, covered entities were al-
lowed to use or disclose demographic information about an indi-
vidual as well as dates relating to the provision of health care to 
an individual for the purpose of raising funds for the covered enti-
ty’s own benefit without obtaining prior authorization from the 
individual.
81
 In the 2000 Final Rule, HHS imposed five require-
ments on fundraising efforts engaged in without prior authoriza-
tion. First, the fundraising must be for the covered entity’s own 
benefit.
82
 That is, a covered entity could not use or disclose an in-
dividual’s PHI to help a second organization raise funds for the 
second organization’s benefit.
83
 Second, the covered entity must 
include a statement in a document called a notice of privacy prac-
tices informing individuals that their PHI may be used and dis-
closed for fundraising purposes.
84
 Third, the covered entity must 
include in its fundraising communications a description of how 
individuals may opt out of receiving further fundraising commu-
nications.
85
 Fourth, the covered entity must make reasonable ef-
forts to ensure that individuals who opt out of receiving future 
fundraising communications are not sent such communications.
86
 
Finally, the PHI used or disclosed by the covered entity must be 
limited to demographic information and dates of health care.
87
 
Other information, such as an individual’s diagnosis, the specific 
treatments provided to the individual, the name of the individu-
al’s treating physician, or the name of the hospital department in 
which the individual received health care, could not be used or 
disclosed without prior authorization.
88
 Covered entities that ad-
 
 80. Id. at 82,514 (“In the final rule, we narrow the circumstances under which covered 
entities must obtain the individual’s authorization to use or disclose protected health in-
formation for fundraising purposes.”). 
 81. Id.  
 82. Id. at 82,820 (“A covered entity may use, or disclose . . . the following [PHI] for the 
purpose of raising funds for its own benefit . . . .”). 
 83. Id. at 82,514 (“Any use or disclosure for fundraising purposes that does not meet 
the requirements . . . requires authorization. Specifically, covered entities must obtain the 
individual’s authorization to use or disclose [PHI] to raise funds for any entity other than 
the covered entity. For example, a covered entity must have the individual’s authorization 
to use [PHI] about the individual to solicit funds for a non-profit organization that engages 
in research, education, and awareness efforts about a particular disease.”). 
 84. Id. at 82,820.  
 85. Id.  
 86. Id.  
 87. Id. (“A covered entity may use, or disclose . . . the following [PHI] for its own bene-
fit, without an authorization . . . (i) Demographic information relating to an individual; 
and (ii) dates of health care provided to an individual.”). 
 88. See, e.g., Christopher Cloud, Fund Raising Hits a Privacy Barrier: HIPAA Rule 
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hered to these requirements were considered to be engaged in 
“health care operations” within the first level of patient permis-
sion described in Part I of this article; thus, no prior authoriza-
tion was required.
89
 
The fundraising approach HHS selected in its 2000 Final Rule 
appears to have been shaped in large part by the comments HHS 
received during the notice-and-comment rulemaking process. Ac-
cording to HHS, many commenters argued that it would be “time 
consuming and costly” for non-profit health care providers to ob-
tain prior patient authorization for fundraising.
90
 These com-
menters argued that an authorization requirement could “lead to 
a decrease in charitable giving.”
91
 Comments such as these per-
haps explain HHS’s removal of the authorization requirement 
that was proposed in the 1999 Proposed Rule. 
The limitations HHS imposed on permissible fundraising activ-
ities in its 2000 Final Rule also appear to have been shaped by 
public comment. According to HHS, numerous commenters ex-
plained that they did not need access to all PHI, just patient 
names, addresses, and telephone numbers, to carry out fundrais-
ing, and that the use or disclosure of other information by covered 
entities could “unnecessarily intrude[] on individual privacy.”
92
 In 
addition, several commenters explained that “disease or condi-
tion-specific letters requesting contributions, if opened by the 
wrong person, could reveal personal information about the in-
 
Will Force Healthcare Organizations to Rethink Development Outreach, MOD. 
HEALTHCARE, Jan. 13, 2003, at 21 (“Unless a patient signs a special authorization, the 
HIPAA privacy rule will limit fund-raisers’ access to a patient’s name, address, age, gen-
der, insurance status and the date the individual was treated. Many analysts interpret the 
privacy rule to mean that fund-raisers cannot access information about the doctor or prac-
tice area where a patient was treated.”); Mary Chris Jaklevic, Healthcare Donations 
Surge, MOD. HEALTHCARE, Sept. 10, 2001, at 34 [hereinafter Jaklevic, Healthcare Dona-
tions Surge] (explaining that under the 2000 regulations, development officers will not 
have access to patient medical data for fundraising; “[f]or example, fund-raisers could not 
determine which patients received cancer care, and therefore would be likely candidates to 
hit up for funding of a new linear accelerator”). 
 89. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. 
Reg. at 82,546 (“[I]n the final rule we define fundraising on behalf of a covered entity to be 
a health care operation.”); id. at 82,804 (defining health care operations to include 
“[c]onsistent with the applicable requirements of § 164.514 . . . fundraising for the benefit 
of the covered entity”). 
 90. Id. at 82,716. 
 91. Id. at 82,718 (“We agree with commenters that our proposal could have adversely 
effected charitable giving, and accordingly make several modifications to the proposal.”). 
 92. Id. 
TOVINO 484 (DO NOT DELETE) 4/18/2014  9:12 AM 
1178 UNIVERSITY OF RICHMOND LAW REVIEW [Vol. 48:1157 
tended recipient.”
93
 These comments perhaps explain HHS’s re-
quirement in the 2000 Final Rule that only demographic infor-
mation and dates of health care could be used or disclosed for 
fundraising. 
Certainly not everyone agreed with HHS’s approach to fund-
raising in the 2000 Final Rule. Joel Simon, Director of Gift Plan-
ning at the charitable foundation of Greater Baltimore Medical 
Center, responded to the final rule by criticizing its limitations on 
ways of searching for grateful patients: “‘You need to find the 
needle in the haystack of 240,000, and HIPAA took away our 
magnet.’”
94
 
C.  The 2009 HITECH Legislation 
The federal government’s approach to fundraising held steady 
until ARRA began working its way through Congress in early 
2009. On January 28, 2009, an amendment to ARRA proposed to 
the House would have struck fundraising from the definition of 
“health care operations,” thereby removing fundraising from the 
first level of patient permission and moving it to the third; that is, 
covered entities would be required to obtain prior written author-
ization for all uses and disclosures of PHI for fundraising.
95
 The 
amendment, which was unsuccessful, was patient advocates’ final 
pre-ARRA attempt to give more weight to health information con-
fidentiality than to health care philanthropy.
96
 
Less than three weeks later, on February 17, 2009, President 
Obama signed ARRA, including HITECH, into law.
97
 HITECH 
 
 93. Id. 
 94. Jaklevic, Healthcare Donations Surge, supra note 88, at 34. 
 95. See 155 CONG. REC., H702 (daily ed. Jan. 28, 2009) (proposing to amend ARRA by 
stating: “Fundraising.—Fundraising for the benefit of a covered entity shall not be consid-
ered a health care operation for purposes of section 164.501 of title 45, Code of Federal 
Regulations”). 
 96. See AHP, After ARRA, supra note 63 (“Prior to final passage of ARRA, there was a 
pitched battle between ardent patient privacy advocates and those representing health 
care providers and employers about the extent to which the existing protections should be 
strengthened. . . . [Patient] [a]dvocates convinced House members to toss the word  ‘fund-
raising’ . . . . [Then, the Association for Healthcare Philanthropy] and other organizations 
launched a lobbying effort, saying the Office for Civil Rights had told them that in six 
years it had received no complaints of privacy violations related to fundraising. The [phi-
lanthropy] groups were victorious, and the House-Senate conference committee removed 
the sentence dealing with fundraising but retained the restrictions on marketing.”). 
 97. Ed Jones, ARRA’s HITECH Privacy Provisions Apply HIPAA Security Rule to 
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contained two consecutive provisions that specifically addressed 
fundraising and directed HHS to make certain changes to the 
Privacy Rule’s fundraising provisions. The first provision re-
quired HHS to provide by rule that “any written fundraising 
communication that is a healthcare operation . . . shall, in a clear 
and conspicuous manner, provide an opportunity for the recipient 
of the communications to elect not to receive any further such 
communication.”
98
 In the second provision, HITECH stated: 
“When an individual elects not to receive any further such com-
munication, such election shall be treated as a revocation of au-
thorization . . . .”
99
 
The two statutory provisions were curious for several reasons. 
First, HHS already required individuals be provided the oppor-
tunity to elect not to receive further fundraising communications, 
so the only new requirement in the first provision was that the 
opportunity given to the individual to opt out must be “clear and 
conspicuous.”
100
 The statutory requirement for a “clear and con-
spicuous” opportunity to opt out was unusual for federal health 
law. That is, Congress usually sets broad policy mandates in leg-
islation and HHS usually establishes detailed implementation 
procedures in regulations.
101
 Here, Congress included in its legis-
lation detailed implementation provisions addressing the manner 
of information presentation. 
Moreover, the second HITECH provision did not really make 
sense. Since individuals were not required to authorize covered 
entities to use their limited demographic information and dates of 
health care for fundraising under the 2000 Final Rule, HITECH’s 
requirement that a patient’s election not to receive further com-
munications be treated as a revocation of such authorization was 
odd.
102
 
 
Business Associates, HIPAA.COM, http://www.hipaa.com/2009/02/arras-hitech-privacy-pro 
visions-apply-hipaa-security-rule-to-business-associates/ (last visited Apr. 14, 2014). 
 98. Health Information Technology for Economic and Clinical Health Act, Pub. L. No. 
111-5, § 13406(b), 123 Stat. 115, 269 (2009). 
 99. Id. 
 100. Id.; see AHP, After ARRA, supra note 63 (reporting that a HIPAA attorney 
thought it unusual for HITECH to have “such specific implementation details, typically 
left up to rules issued by federal agencies” especially when “the new provision essentially 
repeats requirements in the privacy rule”). 
 101. See id. 
 102. See, e.g., Letter from Claudia A. Looney, Senior Vice President of Dev., Children’s 
Hosp. of L.A., to U.S. Dep’t of Health & Human Servs. 2 (Aug. 25, 2010) (“The use of the 
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D.  The 2010 Proposed Rule 
After President Obama signed HITECH into law, the health 
care industry eagerly awaited HHS’s interpretation of the curious 
HITECH provisions.
103
 On July 14, 2010, HHS released a pro-
posed rule (“2010 Proposed Rule”) that would modify the Privacy 
Rule in accordance with HITECH.
104
 In the preamble preceding 
the proposed rulemaking, HHS highlighted the extent to which 
the rulemaking would strengthen confidentiality protections in 
the context of fundraising by imposing new limitations on the use 
and disclosure of PHI for fundraising.
105
 Later in the rulemaking, 
in a section designed to highlight the benefits that would flow to 
individuals as a result of the rulemaking, HHS mentioned again 
the extent to which it was strengthening confidentiality protec-
tions by imposing restrictions on fundraising.
106
 
Indeed, part of HHS’s 2010 Proposed Rule would have 
strengthened individuals’ confidentiality protections in the con-
text of fundraising. As required by HITECH, HHS proposed to 
strengthen an individual’s ability to recognize the opportunity to 
opt out of receiving future fundraising communications by requir-
ing the opt-out language to be presented to individuals in a “clear 
and conspicuous” manner.
107
 Although not required by HITECH, 
HHS also proposed to require that the method for an individual to 
 
term ‘authorization’ is confusing in the context of an ‘opt-out.’ Revocation of authorization 
for an opt-out seems to require using a legal document similar to the HIPAA Authoriza-
tion Form currently used by fundraisers when there is need to use or disclose . . . .”). 
 103. See, e.g., Judd A. Harwood, Have You Seen My HIPAA Regulations, BIRMINGHAM 
MED. NEWS BLOG (Nov. 21, 2012, 7:52 AM), http://birminghammedicalnews.blogspot. 
com/2012/11/have-you-seen-my-hipaa-regulations.html (referencing the health care indus-
try’s long wait for the Final Regulations); Bill Mountcastle, HIPAA Rule Brings about Fa-
vorable Changes to Fundraising, HEALTH PHILANTHROPY SERVS. GRP. (Mar. 26, 2013), 
http://www.health-philanthropy.com/index.php?option=com_lyftenbloggie&view=entry& 
category=bloggies&id=5%3Ahipaa-rule-brings-about-favorable-changes-to-fundraising&It 
emid=15 (stating that the Final Regulations give “long-awaited clarification regarding the 
use of health information for hospital fundraising”). 
 104. See Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under 
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 
40,868 (proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164).  
 105. See id. at 40,869 (“These provisions . . . [establish] new limitations on the use and 
disclosure of protected health information for . . . fundraising purposes . . . .”). 
 106. Id. at 40,909 (“Also, individuals’ rights with respect to fundraising communica-
tions would be strengthened.”). 
 107. Id. at 40,896, 40,922 (“With each fundraising communication sent to an individual 
under this paragraph, a covered entity must provide the individual with a clear and con-
spicuous opportunity to elect not to receive any further fundraising communications.”). 
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elect not to receive further fundraising communications not pose 
an “undue burden” or be “more than nominal.”
108
 In the preamble 
to the 2010 Proposed Rule, HHS encouraged covered entities to 
“consider the use of a toll-free phone number, an e-mail address, 
or similar opt out mechanism that would provide individuals with 
a simple, quick, and inexpensive way to opt out of receiving fu-
ture communications.”
109
 HHS also explained its belief that re-
quiring individuals to opt out by sending a letter through the U.S. 
mail would constitute an undue burden.
110
 HHS further proposed 
that a covered entity not be able to condition treatment or pay-
ment on an individual’s choice with respect to receiving fundrais-
ing communications.
111
 This proposal, HHS believed, would im-
plement the curious language in HITECH that an election by an 
individual not to receive further fundraising communications be 
treated as a revocation of authorization.
112
 HHS’s final proposal 
designed to strengthen confidentiality protections in the context 
of fundraising was a proposal that covered entities not be able to 
send fundraising communications to an individual who had elect-
ed not to receive such communications.
113
 Before, covered entities 
only had to make “reasonable efforts” to ensure that those indi-
viduals who had opted out of receiving fundraising communica-
tions were not sent such communications.
114
 Now, covered entities 
would be expected to actually abide by an individual’s request not 
to receive further fundraising communications.
115
 
In addition to these proposals that were highly touted as in-
creasing confidentiality protections in the context of fundrais-
ing,
116
 HHS also quietly solicited public comment on other provi-
sions that would decrease confidentiality protections. That is, 
HHS solicited public comment on whether to expand the classes 
of PHI that a covered entity may use and disclose for fundraising 
 
 108. See id.  
 109. Id. at 40,886. 
 110. Id.  
 111. Id. at 40,896, 40,922 (proposing 45 C.F.R. § 164.514(f)(1)(ii)(C)). 
 112. Id. at 40,896–97. 
 113. Id. at 40,897, 40922–23. 
 114. Id. at 40,897 (internal quotation marks omitted); see also supra text accompanying 
note 86. 
 115. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under 
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at 
40,897. 
 116. See supra text accompanying note 105. 
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purposes from just demographic information and dates of health 
care to other information, including the name of the hospital de-
partment that provided health care services to the individual.
117
 
Explaining its solicitation of public comment on this topic, HHS 
cited concerns expressed by some covered entities that additional 
classes of information were needed to successfully engage in 
grateful patient fundraising.
118
 
E.  The 2013 Final Rule 
Almost four years after President Obama signed HITECH into 
law, HHS issued its Final Regulations implementing HITECH. 
Published on January 25, 2013,
119
 and technically corrected on 
June 7, 2013,
120
 the Final Regulations contain both expected and 
surprising provisions that increase and decrease confidentiality 
protections in the context of fundraising, respectively. 
As expected, and as required by HITECH, HHS added a re-
quirement that the opportunity to elect not to receive further 
fundraising communications be clear and conspicuous: “With each 
fundraising communication made to an individual under this 
paragraph, a covered entity must provide the individual with a 
clear and conspicuous opportunity to elect not to receive any fur-
ther fundraising communications.”
121
 Although not required by 
HITECH, HHS also added other provisions it had proposed that 
 
 117. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under 
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at 
40,897 (“In addition to the above modifications proposed in response to the HITECH Act, 
we also solicit public comment on the requirement at § 164.514(f)(1) which limits the in-
formation a covered entity may use or disclose for fundraising demographic information 
about and dates of health care service provided to an individual.”). 
 118. Id. (“Since the promulgation of the Privacy Rule, certain covered entities have 
raised concerns regarding this limitation, maintaining that the Privacy Rule’s prohibition 
on the use or disclosure of certain treatment information without an authorization, such 
as the department of service where care was received and outcomes information, harms 
their ability to raise funds from often willing and grateful patients.”). 
 119. See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Noti-
fication Rules under the Health Information Technology for Economic and Clinical Health 
Act and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 5566, 5700 (Jan. 25, 
2013) (to be codified at 45 C.F.R. pts. 160, 164). 
 120. See Technical Corrections to the HIPAA Privacy, Security, and Enforcement 
Rules, 78 Fed. Reg. 32,466, 32,466 (June 7, 2013) (to be codified at 45 C.F.R. pt. 160, 164). 
 121. See Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Noti-
fication Rules under the Health Information Technology for Economic and Clinical Health 
Act and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. at 5700; see also id. 
at 5618 (summarizing HITECH’s new fundraising language). 
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supported an individual’s ability to opt out of receiving further 
fundraising communications. For example, HHS finalized the 
provision requiring the opt-out method not to pose an undue bur-
den or exceed a nominal cost.
122
 HHS also finalized the provision 
it had proposed prohibiting covered entities from making fund-
raising communications to individuals who had opted out of re-
ceiving further communications.
123
 Moreover, HHS finalized the 
provision prohibiting covered entities from conditioning “treat-
ment or payment on [an] individual’s choice with respect to the 
receipt of fundraising communications.”
124
 Although not in the Fi-
nal Regulations, HHS also clarified in the preamble to the Final 
Regulations that covered entities must not use or disclose more 
than the minimum amount of information necessary to accom-
plish their fundraising activities.
125
 All four of these regulatory 
provisions plus the preamble clarification may be viewed as in-
creasing the confidentiality protections available to individuals 
who wish not to have their PHI used or disclosed for fundraising 
purposes. 
As it did in its 2010 Proposed Rule, in the Final Regulations 
HHS made much of the way these new provisions would increase 
confidentiality in the context of fundraising. On the first page of 
the preamble to the Final Regulations, HHS explained that it was 
“[s]trengthen[ing] the limitations on the use and disclosure of 
protected health information for . . . fundraising purposes.”
126
 
HHS stated several times thereafter that the Final Regulations 
“establish new limitations on the use and disclosure of protected 
health information for . . . fundraising purposes.”
127
 
Notwithstanding the emphasis HHS gave to its heightened 
confidentiality protections in the context of fundraising, the Final 
Regulations also contained somewhat surprising provisions that 
allow covered entities to expand the classes of PHI that may be 
used or disclosed for fundraising purposes.
128
 In addition to demo-
 
 122. See id. at 5700. 
 123. Id.  
 124. Id.  
 125. Id. at 5622. 
 126. Id. at 5566. 
 127. Id. at 5568. 
 128. Id. at 5620 (“We generally adopt the proposals in the final rule, as well as allow 
certain additional types of protected health information to be used or disclosed for fund-
raising purposes.”). 
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graphic information (including name, address, other contact in-
formation, age, gender, and date of birth) and dates of health care 
provided to an individual, the Final Regulations now allow cov-
ered entities to use and disclose information relating to the de-
partment of service from which the individual received care, as 
well as information regarding the individual’s treating physician 
and health outcomes.
129
 HHS explained that department of service 
information, treating physician information, and outcome infor-
mation were the three categories of information most frequently 
identified by commenters as necessary for targeting fundraising 
communications to potentially grateful patients.
130
 
Although the Final Regulations do not provide further detail 
about these three classes of PHI, HHS clarifies in its preamble 
language that department of service information includes infor-
mation about the general department from which the patient re-
ceived treatment, such as the cardiology department, the oncolo-
gy department, or the pediatrics department.
131
 As far as outcome 
information, HHS clarifies in the preamble that covered entities 
would be permitted to use and disclose any information regarding 
the death of the individual or any other sub-optimal result of 
treatment or services in order to screen out certain individuals for 
the receipt of fundraising communications.
132
 
In the preamble to the Final Regulations, HHS did not specifi-
cally identify the exact number of commenters who persuaded 
them to expand the classes of PHI that could be used or disclosed 
for fundraising.
133
 A careful reading of the preamble suggests that 
they received more comments in favor of expanding the classes of 
PHI that could be used or disclosed for fundraising than com-
ments opposed to such expansion. In one part of the preamble, 
HHS provides: “[T]he vast majority of commenters supported al-
lowing the use or disclosure of additional protected health infor-
mation for fundraising.”
134
 Later, HHS explained that “a small 
 
 129. Id. at 5700; see also id. at 5622 (“[T]his final rule also allows covered entities to 
use and disclose department of service information, treating physician information, and 
outcome information for fundraising purposes.”). 
 130. Id. at 5622. 
 131. Id. 
 132. Id. 
 133. See infra Part IV for a detailed discussion of the number and contents of the com-
ments received by HHS.  
 134. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notifica-
tion Rules under the Health Information Technology for Economic and Clinical Health Act 
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minority of commenters opposed allowing the use of additional 
protected health information to target fundraising efforts, citing 
privacy concerns with doing so.”
135
 
In summary, HHS changed tack with respect to its approach to 
fundraising three times in the last decade and a half. In its 1999 
Proposed Rule, HHS would have required prior written authori-
zation for all PHI uses and disclosures for fundraising. That is, in 
2000, HHS initially classified fundraising as requiring the third 
(and highest) level of patient permission: prior written authoriza-
tion. Over a year later, in its 2000 Final Rule, HHS decided to 
impose fewer confidentiality restrictions on PHI used and dis-
closed for fundraising by allowing two classes of PHI (i.e., demo-
graphic information related to an individual and dates of health 
care provided to an individual) to be used and disclosed for fund-
raising without prior written authorization. That is, in 2000 HHS 
classified the use and disclosure of these two classes of PHI as 
“health care operations” within the first level of patient permis-
sion, requiring no prior written authorization. Thirteen years lat-
er, in 2013, HHS in its Final Regulations removed additional con-
fidentiality restrictions on the use and disclosure of PHI for 
fundraising by allowing additional classes of PHI (i.e., depart-
ment of service, treating physician, and outcome information) to 
be used and disclosed for fundraising without prior written au-
thorization. That is, HHS increased the number of information 
uses and disclosures that fall within the first level of patient 
permission, thus requiring no prior written authorization. The 
question is whether the current approach is appropriate. As dis-
cussed in more detail in Parts IV and V, I believe it is not. 
III.  THE BUSINESS OF HEALTH CARE PHILANTHROPY 
To determine whether HHS’s current approach to fundraising 
is appropriate, an individual’s interest in maintaining the confi-
dentiality of his or her health information must be balanced 
against a health care provider’s interest in obtaining, using, and 
disclosing PHI for fundraising purposes. This balancing requires 
 
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. at 5620. According to 
HHS, “These commenters stated that the use of additional protected health information 
would streamline their fundraising efforts and ensure that individuals were sent commu-
nications about campaigns that would be meaningful to their experiences.” Id. 
 135. Id.  
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a careful examination of the business of health care philanthropy, 
including the many benefits. 
In 2012, the most recent year for which data is available, chari-
table giving in all industries totaled $316.23 billion.
136
 Approxi-
mately three-quarters of that amount—$228.93 billion in 2012—
came from individuals; that is, non-corporations and non-
foundations.
137
 Charitable giving to health organizations, the sub-
ject of this article, totaled $28.12 billion in 2012.
138
 Historically, 
more than three-quarters of the amount given to health organiza-
tions has come from individuals.
139
 
Philanthropy has helped found, build, and maintain some of 
the country’s oldest and finest healthcare institutions. New Orle-
ans’s historic Charity Hospital “was founded as a result of a crea-
tive estate plan of Jean Lois, a French seaman, in 1735.”
140
 Los 
Angeles’s famous Cedars-Sinai Medical Center “was dedicated, in 
1902, through the generosity of the city’s Jewish community.”
141
 
San Francisco’s French Hospital, “California’s oldest existing 
hospital, was established by a relief society” founded for the pur-
pose of serving the sick and furnishing assistance to individuals 
without resources, among other purposes.
142
 
 
 136. See Mark Hrywna, Giving Gains, Estimated at $316.23 Billion for 2012, 
NONPROFIT TIMES (June 18, 2013), http://www.thenonprofittimes.com/news-articles/giv 
ing-gain-estimated-at-316-23-billion-for-2012/; Giving USA: Charitable Donations Grew in 
2012, But Slowly, Like the Economy, LILLY FAMILY SCH. OF PHILANTHROPY (June 18, 
2013), http://www.philanthropy.iupui.edu/news/article/giving-usa-2013 [hereinafter Giving 
USA]. 
 137. See Giving USA, supra note 136. 
 138. See id. For an overview of numbers reported by other sources and for previous 
years, see Rum & Wright, supra note 65, at 55 (reporting that charitable giving to the 
health care industry, including academic medical centers, health systems, and community 
hospitals, totaled $4.8 billion in 2009); Michael L. Bentz et al., Fundraising and Philan-
thropy in Plastic Surgery: An Essential Tool for Academic Excellence, 127 PLASTIC 
RECONSTRUCTIVE SURGERY 2108, 2108 (2011) (reporting that educational institutions, in-
cluding academic medical centers, received approximately seventeen percent of total chari-
table giving and that health initiatives received seven percent of total charitable giving); 
Getz, supra note 64, at 12 (reporting that the total amount donated to hospitals was $7.9 
billion in 2006 and $8.3 billion in 2007). 
 139. See, e.g., Lowman, supra note 64, at 3 (providing data from 2008 and noting that 
of the $8.6 billion in donations given to health care institutions, eighty-five percent of 
those donations came from individuals; that is, non-foundations and non-corporations). 
 140. Edie E. Zusman et al., Philanthropy Funding for Neurosurgery Research and Pro-
gram Development, 73 NEUROSURGERY 177, 177 (2013). 
 141. Id. 
 142. Id. 
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The largest known gift to an American health care institution 
is the $400 million gift given in 2007 by businessman Denny San-
ford to the Sioux Valley Hospitals & Health System, located in 
Sioux Falls, South Dakota.
143
 The health system has since been 
renamed Sanford Health.
144
 Other illustrative major gifts to 
American health care institutions include the $75 million given 
by the Schmidt Family Foundation to Boca Raton Community 
Hospital in Florida,
145
 the $60 million gift given by A.B. Hudson to 
Shriners Hospital for Children,
146
 the $4 million gift given by 
Richard M. and Yvonne Hamlin to Summa Health System in 
Ohio,
147
 and the $100 million regularly raised through gifts each 
year to New York University’s Langone Medical Center.
148
 
Philanthropic donations support a wide variety of health care 
initiatives and related educational missions.
149
 In the context of 
academic medical centers, which typically include a medical 
school and at least one affiliated teaching hospital,
150
 philanthro-
 
 143. See Kelby Krabbenhoft, Philanthropy: A Priceless Lesson in Healthcare Leader-
ship—The Sanford Health Story, 24 FRONTIERS HEALTH SERVS. MGMT. 3, 4 (2008) (de-
scribing how Denny Sanford’s $400 million gift to support the institution that was re-
named Sanford Health “(the largest known gift to an American healthcare organization)” 
came about); Loren Shook, Building a Culture of Philanthropy from the Inside Out, 24 
FRONTIERS HEALTH SERVS. MGMT. 23, 23 (2008) (discussing the $400 million Sanford 
Health gift); Susan Kreimer, Mega Gifts Let Hospitals Rapidly Expand Their Missions, 
HOSPS. & HEALTH NETWORKS, Mar. 2007, at 26 (discussing the $400 million Sanford 
Health gift). 
 144. See About Us, SANFORD LUVERNE, http://www.sanfordluverne.org/about/ (last vis-
ited Apr. 14, 2014) (noting that the Sioux Valley Health System was renamed Sanford 
Health after Danny Sanford’s $400 million gift). 
 145. See Stephanie Strom, Florida: $75 Million Donated to Hospital, N.Y. TIMES, Jan. 
31, 2007, at A15 (“The Boca Raton Community Hospital announced that it had received 
$75 million from the Schmidt Family Foundation, one of the largest gifts given to a hospi-
tal. The money will help underwrite a new academic medical center focusing on hospital 
safety.”). 
 146. See Tammy Robins, Shriners Hospitals for Children Receives $60 Million Donation 
Largest Donation in Organization’s History, LADUE-FRONTENAC PATCH (Missouri), (Oct. 
16, 2011), http://ladue-frontenac.patch.com/groups/around-town/p/shriners-hospitals-for-
children-receives-60-million-d7e9224de9b. 
 147. See Summa Health System Receives Largest Philanthropic Gift in Organization’s 
History, SUMMA HEALTH SYS. (July 23, 2013), http://www.summahealth.org/pressroom/all 
news/2013/summa-health-system-receives-largest-philanthropic-gift-in-organizations-hist 
ory. 
 148. See Grateful Patients Build, supra note 64. 
 149. See Park H. Haussler, Philanthropy for Patient Care, HEALTHCARE FIN. MGMT., 
Dec. 1982, at 6.  
 150. Cf. Joseph V. Simone, Understanding Academic Medical Centers: Simone’s Max-
ims, 5 CLINICAL CANCER RES. 2281, 2281 (1999) (describing the educational and patient 
care components of an academic medical center). 
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py has historically supported educational efforts,
151
 research pro-
grams,
152
 clinical initiatives,
153
 and building or other academic in-
frastructure support.
154
 
In the non-academic health care setting, health care buildings, 
including whole hospitals as well as wings, departments, wards, 
units, and centers of hospitals, have been the traditional benefi-
ciaries of philanthropic efforts.
155
 Historically, giving also has 
funded the acquisition and maintenance of expensive medical 
equipment, including x-ray machines, computed tomography 
scanners, magnetic resonance imaging scanners, and positron 
emission tomography scanners.
156
 Several decades ago, when 
third-party payers reimbursed health care primarily on a retro-
spective cost basis,
157
 donations designed to cover daily operating 
costs, such as the cost of a patient’s daily hospital bed charge, 
were discouraged because such donations (viewed by accountants 
and auditors as reductions in costs) were required to be reported 
to third party payers and subtracted from the reimbursement re-
quested by the health care provider.
158
 In the 1980s and 1990s, as 
 
 151. See Bentz et al., supra note 138, at 2111. Educational expenses include hard copy 
and computer based learning materials, resident travel for presentation of papers and 
teaching course attendance, visiting professorships, named lectureships, and international 
surgery mission efforts, among others. Id.  
 152. Id. Research programs include “basic science, translational, and clinical research 
programs.” Id. at 2111 tbl.3. 
 153. Id. 
 154. Id. Building and academic infrastructure support include the development or im-
provement of buildings or areas within buildings, the purchase or donation of pieces of 
equipment, chairs, professorships, and/or program directorships. See id. at 2111. 
 155. See Haussler, supra note 149, at 6 (“Bricks and mortar . . . have been the primary 
beneficiaries of charitable giving.”). 
 156. See Les Cave et al., Philanthropy Makes a Difference: CHRISTUS Health Reaps 
the Benefits of Its Successful Community Efforts in Southern Texas, HEALTH PROGRESS, 
Jan.-Feb. 2008, at 44 (“Many philanthropists are attracted to the idea of making contribu-
tions to build new buildings and acquire high technology like CAT Scans, MRIs and Cath 
labs, especially if this ‘health care’ comes complete with naming rights.”); Haussler, supra 
note 149, at 6 (“[E]quipment and other capital acquisitions have been the primary benefi-
ciaries of charitable giving.”). 
 157. See, e.g., LOUIS C. GAPENSKI, FUNDAMENTALS OF HEALTHCARE FINANCE 70 (2d ed. 
2013) (explaining that cost-based reimbursement involves a third-party payer who agrees 
to reimburse the health care provider for the actual costs incurred in providing health care 
to the insured population; cost-based reimbursement is retrospective in the sense that re-
imbursement is based on the actual services that were delivered to the patient in the 
past). 
 158. See Haussler, supra note 149, at 6 (“Since the beginning of cost-based reimburse-
ment, the industry has discouraged the endowment of free beds, or the underwriting of 
operation costs. In our efforts to ‘maximize’ reimbursement, we have noted that any reduc-
tion of cost shares the gift with third-party payors, and we have concluded in most cases 
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third-party payers moved towards prospective payment sys-
tems,
159
 the health care industry began to change its approach to 
philanthropy, including by encouraging donations that could be 
put towards daily operating expenses.
160
 
Today, health care institutions engage in fundraising to sup-
port an even wider variety of health care initiatives and related 
educational missions. Academic medical centers continue to en-
gage in fundraising to satisfy educational needs, research pro-
grams, clinical initiatives, and building and infrastructure sup-
port.
161
 Nonprofit health care organizations engage in fundraising 
to provide resources to their community-based hospitals and clin-
ics and to improve access to health care and other services for the 
uninsured and under-insured.
162
 Many private health care foun-
dations use philanthropy to serve the economically poor and un-
der-served, including women, children, and seniors who live in 
the community served by the foundation.
163
 Health care philan-
thropy is also used to improve the public’s health through preven-
 
that it is not the intention or desire of the donor to have such sharing.”). 
 159. A prospective payment system may be defined as a payment system in which the 
rates paid by third-party payers are determined by the payer before health care services 
are provided and in which payments are not directly related to a health care provider’s 
costs or charges. See GAPENSKI, supra note 157, at 71–72. 
 160. See Cave et al., supra note 156, at 44 (“And, of course, with the reimbursement 
challenges hospitals and acute care face today, it often is essential to raise money through 
philanthropy to supplement the limited insurance and patient payments received.”); 
Haussler, supra note 149 at 6 (“Now is the time for the healthcare industry to consider a 
change in approach to philanthropy. Two reasons point to this conclusion: Cost-based re-
imbursement will be soon a relic of the past and, [t]here are unmet patient and institu-
tional financial needs. As the healthcare industry moves into the competitive marketplace, 
reasonable provision for capital expansion, education and operations must be built into the 
charge structure. . . . Funding from gifts and bequests for payment of specific patient 
charges can be a means through which an institution may reduce uncollectible accounts, 
thereby strengthening the bottom line.”). 
 161. Bentz et al., supra note 138, at 2111; see also Rum & Wright, supra note 65, at 55 
(“At academic health centers and hospitals, these monies help to fund varied needs includ-
ing capital projects, research programs, educational initiatives, financial aid, and endow-
ments. These gifts clearly support the tripartite academic health center mission of patient 
care, research, and education.”); Wright et al., supra note 64, at 645 (“Philanthropic con-
tributions to academic medical centers from grateful patients support research, patient 
care, education, and capital projects.”). 
 162. See, e.g., Cave et al., supra note 156, at 44 (“[T]he [CHRISTUS] fund’s intent is to 
provide resources to community-based, not-for-profit organizations whose vision, mission 
and goals are consistent with those of CHRISTUS Health. Creating access to health care 
and other services for the uninsured and under-insured in communities served by 
CHRISTUS Health gives specificity to the grants awarded.”). 
 163. See, e.g., id. at 47 (noting that the St. Joseph’s Community Foundation located in 
Paris, Texas, “focuses on programs that serve the economically poor and under-served, 
women and children and seniors . . . .”). 
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tion and wellness programs and through the offering of basic 
health care and disease management for individuals without 
health insurance.
164
 Health care philanthropy is used to support a 
wide range of medical specialties and patient care needs, includ-
ing neurosurgery,
165
 obstetrics and gynecology,
166
 plastic surgery,
167
 
psychiatry,
168
 and rare diseases,
169
 among others. In short, health 
care philanthropy now supports a variety of medical specialties 
and health care needs in a broad range of communities and set-
tings. That is, health care philanthropy has moved well beyond 
its historic purpose of providing financial support of hospital 
“bricks and mortar.”
170
 
Philanthropy is said to be one of the only ways that some 
health care institutions can survive in the current health care en-
vironment, which is characterized by expensive medical technolo-
gies, high uncompensated health care costs, inadequate Medicare 
and Medicaid reimbursement, and rising health care compliance 
costs associated with health care reform.
171
 In addition, philan-
 
 164. See id. at 45 (“[The intent of philanthropy can be] to improve the public’s health 
through prevention and wellness programs or . . . to offer primary care and disease man-
agement for uninsured.”). 
 165. See Zusman et al., supra note 140, at 177 (“In times of fiscal and political uncer-
tainty, philanthropy has become an increasingly important mechanism for building, main-
taining, and expanding neurosurgical research programs.”). 
 166. See Frank A. Chervenak et al., Ethics: An Essential Dimension of Soliciting Phil-
anthropic Gifts from Donors, 203 AM. J. OBSTETRICS & GYNECOLOGY 540, 540 (2010) (“Ob-
stetrics and gynecology continues to experience fiscal pressures that challenge its core 
missions. In such an increasingly economically unforgiving environment, philanthropy will 
become a major source of revenue.”). 
 167. See, e.g., Bentz et al., supra note 138, at 2108 (addressing the need for fundraising 
in the context of academic plastic surgery). 
 168. See Herbert Pardes & Constance E. Lieber, Philanthropy for Psychiatry, 163 AM. 
J. PSYCHIATRY 766, 766–67 (2006) (“With reduced public funding and limited foundation 
support, patient-inspired philanthropy serves as an invaluable alternative to cover much 
of the deserted areas of social need,” including academic psychiatry. “[P]hilanthropy 
should not be an area in which mental illness is given short shrift by provider and fund-
raising organizations”). 
 169. See, e.g., Elie Dolgin, Advocates to Bring Rare Disease Philanthropy Under One 
Umbrella, 16 NATURE MED. 837, 837 (2010) (discussing rare disease philanthropy). 
 170. Cave et al., supra note 156, at 44, 47. 
 171. See, e.g., Ass’n of Healthcare Philanthropy Int’l Conference, With Health-Care Re-
forms, Hospitals Need Philanthropy More, FUND RAISING MGMT., Dec. 1993, at 47 (stating 
that philanthropy is necessary due to the financial pressures brought about by health care 
reform); Frequently Asked Questions, HUNTINGTON HOSP., http://www.huntingtonhospital. 
com/Main/GivingFAQ.aspx (last visited Apr. 14, 2014) (“While Huntington Hospital has a 
number of income sources, including insurance reimbursements and investment income, 
the hospital is heavily dependent on private support from this community to maintain our 
level of excellence.”).  
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thropy is said to be one of the most vital and important sources of 
revenue and financial support for health care institutions because 
it is frequently unrestricted and can be used in any area of high 
organizational or institutional need.
172
 
Today, health care philanthropy is a big business supported by 
attorneys,
173
 consultants,
174
 data connection organizations,
175
 and 
professional associations.
176
 Services offered by health care phi-
lanthropy experts include grateful patient fundraising semi-
nars,
177
 webinars,
178
 and workshops,
179
 as well as blog posts ad-
 
 172. Rosalyn Stewart et al., Success in Grateful Patient Philanthropy: Insights from 
Experienced Physicians, 124 AM. J. MED. 1180, 1184 (2011) (“Patient philanthropy can be 
especially transformative because it is often unrestricted, thereby allowing for new and 
creative ventures.”); Wright et al., supra note 64, at 649 (“Grateful patient philanthropy is 
an essential part of keeping academic medical centers (AMC) moving forward . . . because 
it is often unrestricted, and can allow for innovation in areas of high institutional need.”); 
see also Zusman et al., supra note 140, at 178 (“For years, some neurosurgeons have es-
chewed philanthropy, but the profession must now view it as an important source of reve-
nue.”). 
 173. Adam H. Greene & Kristen R. Blanchette, Time to Take Advantage of HIPAA Om-
nibus Rules “Good News”: Fundraising, Research, and Student Immunization Records, 
DAVIS WRIGHT TREMAINE LLD (Apr. 2, 2013), http://www.dwt.com/Time-to-Take-Advan 
tage-of-HIPAA-Omnibus-Rules-Good-News-Fundraising-Research-and-Student-Immuniza 
tion-Records-04-02-2013/ (“The Omnibus Rule now also permits the use of department of 
service, treating physician, outcome information, and health insurance status.”). Bob Bel-
fort, a partner at Manatt, Phelps & Phillips, explains that many of his hospital clients 
have an interest in targeting fundraising communications based on the nature of the 
health care services received by the patient and the identity of the patient’s physician. See 
HIPAA Final Rule Brings Changes to Marketing, Fundraising, HEALTHCARE FIN. NEW 
(Mar. 11, 2013), http://www.healthcarefinancenews.com/news/hipaa-final-rule-brings-chan 
ges-marketing-fundraising. Many of Belfort’s hospital clients also have physicians on their 
medical staffs “make personal appeals to the patients.” Id. Belfort admits that, “I don’t 
know whether patients will have a negative reaction to getting solicitations that indicate 
fundraisers have looked at their data in more detail.” Id.  
 174. See, e.g., Healthcare, GRETZENBACH, GLIER & ASSOCIATES, http://www.grenze 
bachglier.com/healthcare.html (last visited Apr. 14, 2014) (marketing themselves as 
“[c]onsultants in [p]hilanthropic [m]anagement” and listing dozens of health care industry 
clients including academic medical centers, hospitals, research institutes, and hospices, 
among others); Foster Physician Engagement, THIRD SECTOR STRATEGY, http://www.third 
sectorstrategy.com/physicians.html (last visited Apr. 14, 2014) [hereinafter Foster Physi-
cian Engagement] (“Third Sector Strategy provides training and resources to engage and 
enable physicians to be vital partners for philanthropy.”).  
 175. See, e.g., Healthcare Funding Solutions, HARRIS CONNECT, http://www.bcharris 
pub.com/images/HarrisConnectHealthcarefundraisingsolutions.pdf  (last visited Apr. 14, 
2014) (marketing itself as the “leader in grateful patient fundraising”). 
 176. See, e.g., Who We Are, ASS’N FOR HEALTHCARE PHILANTHROPY,  http://sharepoint. 
ahp.org/publicationandtools/News/mediakit/Documents/AHPFactSheet.pdf (last visited 
Apr. 14, 2014) [hereinafter AHP, Who We Are] (advertising that “AHP is the leading au-
thority for standards, knowledge, and leadership in health care philanthropy”). 
 177. See, e.g., AFP International Conference on Fundraising, ASS’N OF FUNDRAISING 
PROF’LS, http://www.afpnet.org/Professional/content.cfm?ItemNumber=3097&navItemNu 
mber=550 (last visited Apr. 14, 2014) (advertising various conferences with seminars host-
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dressing best practices in hospital fundraising generally and 
grateful patient fundraising in particular.
180 
The Association for 
Healthcare Philanthropy (“AHP”) is the largest professional or-
ganization dedicated exclusively to assisting charitable efforts in 
health care organizations.
181
 AHP provides education and infor-
mation to “chief development officers . . . major gift officers, an-
nual campaign managers, event coordinators . . . grant writers,” 
and other development personnel in all sectors of the health care 
industry including health care systems, academic medical cen-
ters, general acute care hospitals, specialty hospitals, long-term 
care facilities, hospices, institutionally related foundations, and 
advocacy groups, among others.
182
 “AHP’s 5,000 members repre-
sent more than 2,200 health care facilities in the United States 
and Canada.”
183
 
Understandably, AHP is very much in favor of HHS’s current 
approach to fundraising. Following the January 25, 2013, release 
of the Final Regulations, the President and Chief Executive Of-
ficer of AHP stated:  
[T]he most positive element in the [Final Regulations] is that health 
care providers and their institutionally-related foundations can ob-
tain and use department of service information in order to focus ap-
peals, communications and outreach to those donors and prospects 
most likely to be interested in supporting the specific program relat-
ed to that area of treatment. Reinstating this provision among the 
 
ed by the Association of Fundraising Professionals). 
 178. See, e.g., Developing a Multichannel Grateful Patient Program to Identify Major 
Donor Prospects, ASS’N OF FUNDRAISING PROF’LS, http://afp.peachnewmedia.com/store/sem 
inar/seminar.php?seminar=14929 (last visited Apr. 14, 2014) (advertising a webinar for 
purchase); Recording Information: Grateful Patient Fundraising Webinar, HARRIS 
CONNECT, http://www.bcharrispub.com/patientfundraising?campaign=WODGP (last visit-
ed Apr. 14, 2014). 
 179. See, e.g., Foster Physician Engagement, supra note 174. 
 180. See, e.g., Tom Wilson, Best Practices in Grateful Patient Fundraising, 
MAJORGIFTSGURU, http://majorgiftsguru.com/2009/05/best-practices-in-grateful-patient.ht 
ml (last visited Apr. 14, 2014). 
 181. About Us, ASS’N FOR HEALTHCARE PHILANTHROPY,  http://www.ahp.org/Home/ 
About_Us/Home/About_Us/About.aspx?hkey=5ed66e69-b202-401f-8aa1-3dfa14bdb488 
(last visited Apr. 14, 2014) [hereinafter AHP, About Us]; AHP, Who We Are, supra note 
176. 
 182. AHP, Who We Are, supra note 176. 
 183. AHP, About Us, supra note 181. Regional and state health care philanthropy asso-
ciations also exist; see, e.g., NEW ENGLAND ASS’N FOR HEALTH CARE PHILANTHROPY, http:// 
www.neahp.org (last visited Apr. 14, 2014); OHIO ASS’N FOR HEALTHCARE PHILANTHROPY, 
http://www.ohioahp.us (last visited Apr. 14, 2014). 
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professionals in health care will assist in efficiency and growth for 
health care philanthropy, which better serves communities.
184
 
Experts in health care philanthropy, including AHP, strongly 
recommend grateful patient fundraising.
185
 Indeed, grateful pa-
tients are said to be the most importance source of financial dona-
tions to the health care industry.
186
 A grateful patient may be de-
fined as a patient, or a family member of a patient, grateful for 
the health care received by the patient and from whom an indi-
vidual or institutional health care provider would like to solicit 
funds.
187
 The simple theory behind grateful patient fundraising is 
that patients who are grateful for the health care they have re-
ceived may be more willing to make philanthropic contributions 
compared to less satisfied patients and individuals who have no 
relationship with the soliciting health care institution.
188
 
Grateful patient fundraising can be conducted at two different 
points in time: when the patient is in the hospital or other health 
care institution as an inpatient or outpatient or after the patient 
has been discharged or has returned home.
189
 During the first 
 
 184. Modifications to HIPAA Help Fundraisers Improve Efficiency, WEALTHENGINE 
(Mar. 5, 2013), http://www.wealthengine.com/blog/2013/modifications-hipaa-help-fundrais 
ers-improve-efficiency (internal quotation marks omitted). 
 185. Bullington, supra note 64, at 1; Dianna Dilworth, Past Patients an Untapped 
Fundraising Source: Survey, DIRECT MARKETING NEWS (July 30, 2007), http://www.dm 
news.com/past-patients-an-untapped-fundraising-source-survey/article/98021/. 
 186. See, e.g., Anthony N. DeMaria, Philanthropy and Medicine, 48 J. AM. C. 
CARDIOLOGY 1725, 1725 (2006) (“Perhaps the greatest source of philanthropy is the grate-
ful patient.”); Rum & Wright, supra note 65, at 55 (footnote omitted) (“In 2009, gifts from 
individuals to academic health centers, health systems, and community hospitals in the 
United States totaled $4.8 billion. A substantial proportion of this total—nearly $1 bil-
lion—came from grateful patients.”); Stewart et al., supra note 172, at 1180 (“Support 
from grateful patients is the single most important source for substantive philanthropic 
gifts in medicine.”). 
 187. See Bentz et al., supra note 138, at 2109. 
 188. See GRATEFUL PATIENTS, supra note 62, at 4 (“Anecdotal evidence indicates that 
positive patient experiences lead to increased giving. While much study remains to be 
done on the exact interaction between patient satisfaction, medical outcomes, and donor 
behavior, medical environments . . . appear to support better philanthropic outcomes.”); 
Grateful Patient Program, CLARK MEM’L HOSP., http://www.clarkmemorial.org/patient-
services/grateful-patient-program/ (last visited Apr. 14, 2014) (“We’re often asked by pa-
tients who have such an experience if there’s a way they can express their gratitude and 
appreciation for the care they or a family member received. That’s why we started the 
Grateful Patients & Family Program. . . . Through our Grateful Patient & Family Pro-
gram, you can express your appreciation for the special care you or your loved ones re-
ceived through a special donation to the Clark Memorial Hospital Foundation.”).  
 189. See Bullington, supra note 64, at 3 (explaining that organizations can conduct dai-
ly patient visits and/or send fundraising communications through the mail after patient 
discharge). 
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time period, solicitations may be made in person during a private 
conversation between a patient and an institutional representa-
tive or the patient’s physician. During the second time period, so-
licitations may be mailed, e-mailed, telephoned, or conducted in 
person during a meeting or at a fundraising event. 
According to health care philanthropy experts, timing is every-
thing. Soliciting funds from a patient who is sick and lying in a 
hospital bed or from a patient who has been waiting to see a phy-
sician for several hours is likely to be unsuccessful.
190
 Patients 
have reported frustration with solicitations made very shortly af-
ter health care services are rendered, including one case where a 
patient received a philanthropic solicitation two weeks after mak-
ing a single visit to a hospital for a mere physician consultation.
191
 
Fundraising experts further advise that philanthropic communi-
cations not be scheduled at the same time as hospital and other 
health care bills are to be received by the patient.
192
 A majority of 
first-time patient gifts are made within a year and a half of an 
inpatient stay, however, waiting years after the patient has been 
discharged home and all hospital bills have been paid is not rec-
ommended either.
193
 
IV.  CONFIDENTIALITY ISSUES RAISED BY GRATEFUL PATIENT 
FUNDRAISING 
With this background regarding the benefits of health care phi-
lanthropy and the practice of grateful patient fundraising, this 
article can now assess the confidentiality issues raised by grateful 
patient fundraising. In the health care context, confidentiality 
may be defined as the obligation of a health industry participant 
to prevent the unauthorized or otherwise inappropriate use or 
disclosure of voluntarily given and appropriately gathered health 
 
 190. See Lowman, supra note 64, at 10 (“Bad idea: Ask for a gift while a person is lying 
in a hospital bed, has been sitting in your waiting area for 2 hours, etc.”). 
 191. See DeMaria, supra note 186, at 1725 (“[T]he concept that seeking medical care 
may automatically trigger a request for a donation does seem to straddle the fine line be-
tween appropriate and unseemly.”). 
 192. See Bullington, supra note 64, at 4 (“Messaging and length of time between dis-
charge and solicitation should be tested. You do not want your grateful patients to receive 
their solicitation letters the same day they receive their bills. Working with the billing de-
partment can help alleviate overlap in this area.”). 
 193. See Lowman, supra note 64, at 10 (“But time is limited—the vast majority of first-
time patient gifts come within 18 months of an in-patient visit.)”. 
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information relating to a patient.
194
 Grateful patient fundraising 
raises confidentiality issues because patients voluntarily provide 
health and other information about themselves to treating physi-
cians and hospital support personnel in order to obtain a diagno-
sis and treatment. When a physician or other hospital repre-
sentative uses or discloses that information for a purpose 
unrelated to treatment, the question becomes whether the use or 
disclosure is appropriate without prior patient notification and 
permission. That is, has a physician or other hospital representa-
tive who used or disclosed a patient’s information for fundraising 
violated the patient’s right to confidentiality? 
As discussed in Part II of this article, the Privacy Rule now al-
lows covered entities to use and disclose demographic infor-
mation, insurance information, treating physician information, 
department of service information, and health outcome infor-
mation for fundraising purposes without patient authorization.
195
 
As discussed in more detail below, this article argues that author-
ization should be sought and obtained before any information 
other than demographic information and dates relating to the 
provision of health care (collectively, “demographic information”) 
is used or disclosed for fundraising purposes because: (1) patients 
likely do not expect that their PHI is being used and disclosed for 
fundraising purposes in exchange for their request for and receipt 
of health care and HHS’s new Model Notice does nothing to im-
prove patient expectations in this regard; (2) fundraising is nei-
ther a core function of covered entities nor necessary to support a 
core function of covered entities; (3) a fundraiser who receives and 
uses non-demographic information to create a targeted fundrais-
ing communication, or a third party who reads a targeted fund-
raising communication, could easily determine the patient’s gen-
eral health condition or the health care services requested or 
received by the patient; and (4) a close examination of the com-
ments received by HHS in response to its 2010 Proposed Rule do 
not indicate a shift in public attitudes regarding the appropriate 
balance of confidentiality and philanthropy. Rather, the com-
ments indicate that covered entities still would like to gather, 
use, and disclose as much information as possible about patients 
 
 194. See Tovino, Functional Neuroimaging Information, supra note 11, at 441–42. 
 195. Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.514(f)(1) 
(i)–(vi) (2013). 
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for fundraising purposes and that patients’ rights advocates and 
privacy coalitions still prefer to prioritize patient confidentiality. 
The fact that covered entities would still like to gather, use, and 
disclose an expanded class of PHI for fundraising does not mean 
that philanthropy should, on a normative level, outweigh basic 
patients’ rights. Rather, this article proposes that health infor-
mation confidentiality and health care philanthropy be balanced 
through a more express notification of fundraising and prior au-
thorization requirement. Each of these four arguments will be 
discussed in turn. 
First, one test federal and state lawmakers have used to de-
termine whether health care providers may use and disclose PHI 
for a particular purpose without prior patient authorization is 
whether a patient would reasonably expect that his or her PHI 
would be used and disclosed for such purpose.
196
 For example, 
HHS believes that most patients expect that when they present to 
their primary care physician with a suspected broken arm, or to 
their obstetrician with a suspected pregnancy, that the primary 
care physician or obstetrician will share information with radiol-
ogists and laboratories as necessary to provide or confirm a diag-
nosis.
197
 For this reason, the Privacy Rule does not require the 
 
 196. See, e.g., Standards for Privacy of Individually Identifiable Health Information, 65 
Fed. Reg. 82,462, 82,625 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164) (stating 
that in the context of patient expectations regarding the use and disclosure of PHI for bi-
omedical and behavioral research: “A large number of commenters, however, indicated 
that they did not expect that individually identifiable health information about themselves 
would be used for research purposes without their authorization. Therefore, we retain 
more stringent protections for research disclosures without patient authorization”); 
Standards for Privacy of Individually Identifiable Health Information, 67 Fed. Reg. 
14,776, 14,782–83 (proposed Mar. 27, 2002) (to be codified at 45 C.F.R. pts. 160, 164) (stat-
ing that in the context of whether one covered entity is permitted to disclose PHI to a sec-
ond covered entity for the recipient entity’s health care operations: “The Department be-
lieves that this limitation is necessary in order to protect the privacy expectations of the 
individual. An individual should expect that two providers that are providing treatment to 
the individual, and the health plan that pays for the individual’s health care, would have 
protected health information about the individual for health care operations purposes. 
However, an individual would not expect a health plan with which the individual has no 
relationship to be able to obtain identifiable information from his or her health care pro-
vider”); Texas Medical Records Privacy Act, TEX. HEALTH & SAFETY CODE § 181.005(c)(1) 
(West 2012) (obligating the Executive Commissioner of the Texas Health and Human Ser-
vices Commission, who is responsible for administering the Texas Medical Records Privacy 
Act, to consider “the lives of individuals in th[e State of Texas] and their expectations of 
privacy”). 
 197. See Standards for Privacy of Individually Identifiable Health Information, 64 Fed. 
Reg. 59,918, 59,940 (proposed Nov. 3, 1999) (to be codified at 45 C.F.R. pts. 160–64) (“Our 
proposal is intended to make the exchange of protected health information relatively easy 
for health care purposes and more difficult for purposes other than health care. For indi-
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primary care physician or the obstetrician to obtain the patient’s 
prior written authorization before disclosing information to the 
radiologist or the laboratory.
198
 HHS also believes that most pa-
tients with health insurance expect (and perhaps hope) that their 
health care providers will bill their insurers for health care ser-
vices rendered so that the patients will not have to pay out of 
pocket for their health care services. Again, the Privacy Rule does 
not require a health care provider to obtain prior written authori-
zation from a patient before disclosing the patient’s PHI to the in-
surer for payment or reimbursement purposes.
199
 
 
viduals, health care treatment and payment are the core functions of the health care sys-
tem. This is what they expect their health information will be used for when they seek 
medical care.”); see also Standards for Privacy of Individually Identifiable Health Infor-
mation, 67 Fed. Reg. 53,182, 53,208 (Aug. 14, 2002) (to be codified at 45 C.F.R. pts. 160, 
164) (“In developing the Privacy Rule, the Department balanced the privacy implications 
of uses and disclosures for treatment, payment, and health care operations and the need 
for these core activities to continue. The Department considered the fact that many indi-
viduals expect that their health information will be used and disclosed as necessary to 
treat them, bill for treatment, and, to some extent, operate the covered entity’s health care 
business.”); Uses and Disclosures for Treatment, Payment, and Health Care Operations, 
U.S. DEP’T HEALTH & HUMAN SERVS., http://www.hhs.gov/ocr/privacy/hippa/understand 
ing/coveredentities/usesanddisclosuresfurtpo.html (last visited Apr. 14, 2014) (“Many indi-
viduals expect that their health information will be used and disclosed as necessary to 
treat them, bill for treatment, and, to some extent, operate the covered entity’s health care 
business. To avoid interfering with an individual’s access to quality health care or the effi-
cient payment for such health care, the Privacy Rule permits a covered entity to use and 
disclose protected health information, with certain limits and protections, for treatment, 
payment, and health care operations activities.”). 
 198. Id.; see also Privacy of Individually Identifiable Health Information, 45 C.F.R. § 
164.506(c)(1) (2013) (allowing covered entities to use and disclose PHI for treatment pur-
poses without prior written authorization); Standards for Privacy of Individually Identifi-
able Health Information, 64 Fed. Reg. at 59,940 (“We therefore propose that covered enti-
ties be permitted to use and disclose protected health information without individual 
authorization for treatment and payment purposes, and for related purposes that we have 
defined as health care operations. For example, health care providers could maintain and 
refer to a medical record, disclose information to other providers or persons as necessary 
for consultation about diagnosis or treatment, and disclose information as part of referrals 
to other providers. Health care providers also could use a patient’s protected health infor-
mation for payment purposes such as submitting a claim to a payer. In addition, they 
could use a patient’s protected health information for health care operations, such as use 
for an internal quality oversight review.”). 
 199. See supra notes 197–98; see also 45 C.F.R. § 164.506(c)(1) (allowing covered enti-
ties to disclose PHI for payment purposes without prior written authorization); Standards 
for Privacy of Individually Identifiable Health Information, 65 Fed. Reg. at 82,614 (“Activ-
ities we include in the definition of payment reflect core functions through which health 
care and health insurance services are funded. It would not be appropriate for a rule about 
health information privacy to hinder mechanisms by which health care is delivered and 
financed. . . . Rather, we allow these activities to occur, subject to and consistent with the 
requirements of this rule.”). 
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The question becomes whether patients expect that their 
health care providers will internally use their PHI and disclose 
their PHI to development officers, major gifts officers, institu-
tionally-related foundations, and BAs for fundraising purposes. 
Although it would be helpful, research revealed no empirical re-
search assessing patients’ expectations with respect to the use 
and disclosure of their PHI for fundraising purposes. The ques-
tion thus becomes whether we think that patients would expect 
that their PHI will be used and disclosed for fundraising purposes 
without their prior written authorization in exchange for their 
request for and receipt of treatment. 
I do not believe that patients expect that, as a result of request-
ing and receiving treatment at a hospital or other health care in-
stitution, their physicians and other hospital representatives will 
use and disclose their PHI for fundraising purposes. That is, I do 
not believe that patients have any idea that development officers 
search demographic information to identify patients who live in 
zip codes associated with expensive neighborhoods. I do not be-
lieve that patients know that major gift officers use cash payment 
and Cadillac insurance status
200
 in an attempt to identify patients 
who have the resources to make philanthropic donations. I do not 
believe that patients know, or want, vice presidents of philan-
thropy at their hospitals’ institutionally related foundations—
folks who are very well known, well connected, and social in their 
communities—to be accessing their treating physician’s name and 
their department of service, which can suggest diagnosis or 
health condition as well as the class of health care services re-
quested or received. In summary, I believe that fundraising fails 
the patient expectation test and that a more express prior notifi-
cation and authorization requirement would serve the ethical 
principle of respect for persons, including the obligation to pro-
vide information necessary for autonomous persons to make deci-
sions about what happens to them and their health information.
201
 
 
 200. See generally Jenny Gold, ‘Cadillac’ Insurance Plans Explained, KAISER HEALTH 
NEWS (Mar. 18, 2010), http://www.kaiserhealthnews.org/stories/2009/september/22/cadill 
ac-health-explainer-npr.aspx (describing a “Cadillac” insurance plan as a relatively expen-
sive plan that has excellent benefits and covers even the most expensive treatments). 
 201. See generally NAT’L COMM’N FOR THE PROT. OF HUMAN SUBJECTS OF BIOMEDICAL 
& BEHAVIORAL RESEARCH, U.S. DEP’T HEALTH, EDUC. & WELFARE, ETHICAL PRINCIPLES 
AND GUIDELINES FOR THE PROTECTION OF HUMAN SUBJECTS OF RESEARCH (Apr. 18, 1979) 
[hereinafter BELMONT REPORT], available at http://www.hhs.gov/ohrp/humansubjects/guid 
ance/belmont.html#erespect. 
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My beliefs are supported by analogy to other positions HHS 
has maintained regarding patient expectations. For example, as 
discussed above, it is HHS’s view that patients do expect that 
their PHI will be used and disclosed for treatment and insurance 
reimbursement purposes, but that they do not expect that their 
PHI will be used and disclosed for research purposes.
202
 Thus, 
with a few exceptions, HHS generally requires authorization be-
fore a covered entity can use or disclose PHI for research purpos-
es.
203
 I certainly agree with HHS’s decision to require authoriza-
tion in the research context, and I also think that fundraising, 
like research, is sufficiently unexpected not to allow waiver of pa-
tient authorization. My beliefs are also supported by the Ameri-
can Medical Association’s (“AMA”) Code of Medical Ethics and 
many state health information confidentiality laws, which do not 
contain exceptions to the general duty of confidentiality for fund-
raising and related data collection activities.
204
 Indeed, I associate 
 
 202. See supra note 197; Standards for Privacy of Individually Identifiable Health In-
formation, 65 Fed. Reg. at 82,625 (“A large number of commenters, however, indicated 
that they did not expect that individually identifiable health information about themselves 
would be used for research purposes without their authorization. Therefore, we retain 
more stringent protections for research disclosures without patient authorization.”). 
 203. See 45 C.F.R. § 164.512(i). 
 204. Privacy Policy, MARTIN & SUHEY ORTHOPEDICS, http://martinsuhey.com/privacy-
policy-21 (last visited Apr. 14, 2014) (“In return for the patient’s honesty, the physician 
generally should not reveal confidential communications or information without the pa-
tient’s express consent unless required to disclose the information by law. There are ex-
ceptions to the rule, such as where a patient threatens bodily harm to himself or herself or 
to another person.”); Opinion 5.05-Confidentiality, in CODE OF MEDICAL ETHICS, AM. MED. 
ASS’N, available at http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/ 
code-medical-ethics/opinion505. page? (last updated June 2007) (“The physician should not 
reveal confidential information without the express consent of the patient, subject to cer-
tain exceptions which are ethically justified because of overriding considerations. When a 
patient threatens to inflict serious physical harm to another person or to him or herself 
and there is a reasonable probability that the patient may carry out the threat, the physi-
cian should take reasonable precautions for the protection of the intended victim, which 
may include notification of law enforcement authorities. When the disclosure of confiden-
tial information is required by law or court order, physicians generally should notify the 
patient. Physicians should disclose the minimal information required by law, advocate for 
the protection of confidential information and, if appropriate, seek a change in the law.”); 
Opinion 5.075-Confidentiality: Disclosure of Records to Data Collection Companies, in 
CODE OF MEDICAL ETHICS, AM. MED. ASS’N available at http://www.ama-assn.org/ama/ 
pub/physician-resources/medical-ethics/code-medical-ethics/opinion5075.page? (last updat-
ed June 1998) (stating, with respect to the disclosure of confidential health information to 
data collection companies: “Data collection from computerized or other patient records for 
marketing purposes raises serious ethical concerns. . . . These arrangements may violate 
principles of informed consent and patient confidentiality. Patients divulge information to 
their physicians only for purposes of diagnosis and treatment. If other uses are to be made 
of the information, patients must give their permission after being fully informed about 
the purpose of such disclosures. If permission is not obtained, physicians violate patient 
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biomedical and behavioral research more closely with treatment; 
indeed, between research and fundraising, I would expect my PHI 
to be used by my health care providers for research before it 
would be used for fundraising. 
In order to give patients notice of how they should expect their 
PHI to be used and disclosed, the Privacy Rule does require pa-
tients to be given a document called a “notice of privacy practic-
es.”
205
 The purpose of the notice of privacy practices is to give in-
dividuals “adequate notice of the uses and disclosures of protected 
health information that may be made by the covered entity, and 
of the individual’s rights and the covered entity’s legal duties 
with respect to protected health information.”
206
 Covered entities 
must give the notice of privacy practices to patients at their date 
of first service delivery,
207
 post the notice in a clear and prominent 
location where it is reasonable to expect individuals seeking ser-
vices from the health care provider will be able to read the no-
tice,
208
 and make the notice available to any individual upon re-
quest,
209
 including when the notice is revised.
210
 The Privacy Rule 
does not require patients to read or understand the notice, and it 
does not require the covered entity to explain the notice to pa-
tients.
211
 The empirical literature assessing the use and readabil-
ity of the notice of privacy practices suggests that many notices 
are difficult to read and are written at a much higher reading 
 
confidentiality by sharing specific and intimate information from patients’ records with 
commercial interests. . . . Finally, these arrangements may harm the integrity of the pa-
tient-physician relationship. The trust that is fundamental to this relationship is based on 
the principle that the physicians are the agents first and foremost of their patients.”), 
available at http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-
medical-ethics/opinion5075. page? (last visited Apr. 14, 2014); NEV. REV. STAT. § 
449.720(2) (2012) (“Except as otherwise provided in NRS 108.640, 239.0115, 439.538, 
442.300 to 442.330, inclusive, and 449.705 and chapter 629 of NRS [none of which relate to 
fundraising], discussions of the care of a patient, consultation with other persons concern-
ing the patient, examinations or treatments, and all communications and records concern-
ing the patient are confidential.”). 
 205. See 45 C.F.R. § 164.520. 
 206. See id. § 164.520(a)(1). 
 207. Id. § 164.520(c)(2)(i)(A). 
 208. Id. § 164.520(c)(2)(iii)(B). 
 209. Id. § 164.520(c). 
 210. Id. § 164.520(c)(2)(iv). 
 211. See, e.g., Rachelle S. Stewart, Protective Measures for Private Health Information, 
4 PERSP. HEALTH INFO. MGMT. 1, 5 (2007), available at http://www.ncbi.nlm.nih.gov/pmc/ 
articles/PMC2047293/pdf/phim0004-0005.pdf (“Some facilities simply ask patients to sign 
the Privacy Practice form, but do not take the time to explain its provisions.”). 
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level than plain language.
212
 In addition, the medical and privacy 
literatures suggest that most patients do not even read HIPAA-
required notices of privacy practices or other privacy policies.
213
 
Assuming for the moment that a patient actually reads the no-
tice of privacy practices either at the time of first service delivery 
or in posted form, the required fundraising language can be short 
and non-descriptive and may not actually describe the ambitious 
nature of the fundraising activities undertaken by many covered 
entities. Indeed, on September 16, 2013, HHS released its Model 
Notice designed to comply with the Privacy Rule. The only fund-
raising language contained in the Model Notice provides: “In the 
case of fundraising: We may contact you for fundraising efforts, 
but you can tell us not to contact you again.”
214
 This concise 
statement does nothing to inform patients (or raise patient expec-
tations) regarding the classes of PHI that may be used without 
prior patient authorization or the types of individuals and organi-
zations, including employed major gifts officers, institutionally-
related foundations, and contracted business associates, who may 
receive PHI from covered entities for fundraising purposes. 
A review of covered entities’ actual notices suggests that they 
are not much better than HHS’s Model Notice. The Cleveland 
Clinic Health System (“CCHS”) in Cleveland, Ohio, has a four-
page notice of privacy practices that states, in relevant part: 
“Philanthropic Support. We may use general demographic infor-
mation about you to contact you in an effort to raise funds to sup-
 
 212. See, e.g., Anh T. Ha & Stuart A. Gansky, HIPAA Notice of Privacy Practices Used 
in U.S. Dental Schools: Factors Related to Readability or Lack Thereof, 71 J. DENTAL 
EDUC. 419, 424 (2007) (“Not surprisingly, most U.S. dental schools’ NPPs [notices of priva-
cy practices] are quite difficult to read and at a much higher reading level than plain lan-
guage.”); Steven Walfish & Keely M. Watkins, Readability Level of Health Insurance Port-
ability and Accountability Act Notices of Privacy Practices Utilized by Academic Medical 
Centers, 28 EVALUATION & HEALTH PROFS. 479, 479 (2005) (“The majority (65%) of [notices 
analyzed] were written beyond the 12th-grade reading level, and almost the entire sample 
(90%) fell in the difficult range of reading ease.”). 
 213. See, e.g., Memorandum from Paul M. Schwartz & Daniel Solove, Notice and 
Choice: Implications for Digital Marketing to Youth, to The Second NPLAN/BSMG Meet-
ing on Digital Media and Marketing to Children 2 (June 29-30, 2009), available at http:// 
changelabsolutions.org/sites/default/files/documents/Notice_and_choice.pdf (“An additional 
major problem with notice and choice is that notice is illusory in practice. Privacy policies 
are long, cumbersome, and hard to read. Moreover, most people do not read privacy poli-
cies.”); Observorship Program Guidelines and Evaluation Forms, AM. MED. ASS’N,  availa-
ble at http://www.ama-assn.org/ama/pub/about-ama/our-people/member-groups-sections/ 
interational-medical-graduates/observership-guidelines.page  (last visited Apr. 14, 2014) 
(“[M]ost patients do not read the Notice of Privacy Practices”). 
 214. MODEL NOTICE, supra note 5, at 4. 
TOVINO 484 (DO NOT DELETE) 4/18/2014  9:12 AM 
1202 UNIVERSITY OF RICHMOND LAW REVIEW [Vol. 48:1157 
port CCHS and its operations. We also will tell you how to cancel 
these communications.”
215
 The language is so brief that even if no-
ticed and read, it may not trigger any patient expectations re-
garding the philanthropic activities described in Part III of this 
article. In addition, the language does not appear to have been 
updated in light of the Final Regulations because there is no 
mention of using or disclosing treating physician information, de-
partment of service information, or health outcome information. 
Similarly, New York City’s Memorial Sloan-Kettering Cancer 
Center (“Sloan-Kettering”) has an eight-page notice of privacy 
practices. On page three, Sloan-Kettering states:  
Fundraising. To support our business operations, we may use demo-
graphic and other information about you, including your name, 
where you live or work, your health insurance status, your age and 
gender, [and] the dates that you received treatment . . . in order to 
contact you to raise money to help us operate. We may also share 
this information with [a] . . .  charitable foundation . . . who may con-
tact you to raise money on our behalf.
216
  
Slightly more descriptive than CCHS’s language, this language 
may trigger some patient expectations regarding the philanthrop-
ic activities described in Part III of this article. However, the fact 
that the fundraising paragraph is located on page three of an 
eight-page notice certainly raises the question of whether the 
language would be noticed and read. In addition, the notice does 
not provide individuals with clear notice that they have the right 
to opt out of fundraising activities.
217
 Like CCHS’s language, 
Sloan-Kettering’s language also does not appear to have been up-
dated in light of the Final Regulations because there is no men-
tion of using or disclosing treating physician information, de-
partment of service information, or health outcome information. 
 
 215. Notice of Privacy Practices, CLEVELAND CLINIC HEALTH SYS., http://my.cleveland 
clinic.org/Documents/Legal/npp.pdf (last visited Apr. 14, 2014). 
 216. Notice of Privacy Practices, MEMORIAL SLOAN-KETTERING CANCER CENTER (Sept. 
23, 2013), available at http://www.mskcc.org/sites/files/node/2008/documents/revised-
privacy-practices-eng-201309v1.pdf. 
 217. If the general consent references fundraising activities and allows patients to opt 
out of them, then the Privacy Rule’s requirements may technically be satisfied. Because 
the general consent is not internally referenced, linked, or otherwise attached, however, I 
am unable to determine whether the general consent references fundraising and the ex-
tent to which a patient can opt out of fundraising activities. Id. 
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By final example, Sanford Health in Bismark, North Dakota, 
has a nine-page notice of privacy practices. On page four, the no-
tice states:  
Fundraising communications[.] We may contact you to request a tax-
deductible contribution to support important activities of [Sanford 
Health]. In connection with any fundraising, we may disclose to our 
fundraising staff demographic information about you (e.g., your 
name, address and phone number) and dates on which we provided 
healthcare to you.
218
  
Although Sanford Health’s language is very clear and concise, the 
question, again, is whether patients will find the language on the 
fourth page of the notice and, if so, whether the language will 
trigger patient expectations regarding the philanthropic activities 
described in Part III of this article. Since the language does not 
appear to inform patients that they have the right to opt out of 
receiving fundraising communications, the notice may technically 
not comply with the Privacy Rule.
219
 Like CCHS’s and Sloan-
Kettering’s language, Sanford Health’s language also does not 
appear to have been updated in light of the Final Regulations be-
cause it contains no mention of treating physician information, 
department of service information, or health outcome infor-
mation. 
I do not believe that most patients expect that their PHI will be 
used and disclosed for fundraising. Moreover, I do not believe that 
the Privacy Rule’s notice of privacy practices requirement pro-
vides patients with such an expectation because: (1) many pa-
tients simply do not read notices of privacy practices; and, for 
those patients who do read them; (2) the fundraising language in 
HHS’s Model Notice and in covered entities’ actual notices is too 
brief and insufficiently descriptive to trigger any expectations re-
garding the philanthropic activities described in Part III of this 
article; (3) the fundraising language, even if descriptive, may be 
located deep within a long notice and may not have been specifi-
 
 218. About Sanford Health, SANFORD HEALTH, http://www.sanfordhealth.org/about 
(last visited Apr. 14, 2014); What Is HIPAA?, SANFORD HEALTH, http://www.bis marck. 
sanfordhealth.org/information/HIPAAbrochure.pdf (last visited Apr. 14, 2014). Sanford 
Health merged with Medcenter One in 2012.  
 219. See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 
164.520(b)(1)(iii)(A) (2013) (stating that the notice of privacy practices must include “a 
separate statement informing the individual . . . [i]n accordance with § 164.514(f)(1), the 
covered entity may contact the individual to raise funds for the covered entity and the in-
dividual has a right to opt out of receiving such communications”). 
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cally noticed; (4) some notices do not provide clear statements no-
tifying patients that they have the right to opt out of receiving 
fundraising communications; and (5) most covered entities do not 
appear to have updated their notices of privacy practices in light 
of the Final Regulations. For these reasons, I argue that the use 
of the notice of privacy practices to trigger patient expectations 
regarding fundraising and to provide notice of a patient’s right to 
opt out of receiving fundraising communications is illusory in 
practice.
220
 
The second reason I believe fundraising activities that involve 
PHI other than basic demographic information and dates of 
health care should require prior patient authorization is that 
fundraising is neither a core function of covered entities nor nec-
essary to support the core functions of treatment and payment. 
As background, the Privacy Rule permits covered entities to use 
and disclose PHI without patient authorization when the purpose 
of the use or disclosure is a core function of the covered entity or 
an activity that is necessary to support a core function.
221
 The core 
functions of covered entities include treatment and payment.
222
 
That is, the main reason patients seek care from a health care 
provider is for diagnosis and treatment.
223
 The core function of 
health plans is to pay health care providers for the treatment 
they have provided and to reimburse insured patients for health 
care for which they have already paid.
224
 And, the core function of 
health care clearinghouses is to transmit and translate infor-
mation between and among health care providers, billing compa-
nies, and health care payers with the end goal of ensuring that 
providers get paid for treating patients.
225
 Confidentiality gives 
way to these important, core health care functions. 
 
 220. Schwartz & Solove, supra note at 213, at 1–2. 
 221. See Marketing, U.S. DEP’T HEALTH & HUMAN SERVS. (Apr. 3, 2003), http:// 
www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/marketing.html [hereinaf-
ter HHS on Marketing] (distinguishing marketing activities from the core functions of 
treatment and payment). 
 222. U.S. DEP’T HEALTH & HUMAN SERVS., PROTECTED HEALTH INFORMATION 16 (2003) 
available at http://www.hhs.gov/ocr/privacy/hipaa/understanding/training/udmn.pdf (list-
ing treatment and payment as core functions). 
 223. Id. 
 224. Id. at 15. 
 225. Id.; see also Privacy of Individually Identifiable Health Information, 45 C.F.R. § 
160.103 (2013) (defining health care clearinghouse). 
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The Privacy Rule does allow covered entities to use and dis-
close PHI without prior patient authorization for certain adminis-
trative, financial, and legal purposes that are necessary to sup-
port the core functions of treatment.
226
 For example, federal and 
state laws require hospitals to assess the quality of health care 
they provide,
227
 obtain a license to do business from the relevant 
state agency,
228
 and obtain certification from the Centers for Med-
icare and Medicaid Services if they wish to obtain reimbursement 
for providing health care services to Medicare and Medicaid bene-
ficiaries.
229
 For these reasons, quality assurance, licensing, and 
certification activities are considered necessary to support the 
core functions of treatment and payment and prior patient au-
thorization is not required.
230
 
Even if they are helpful or beneficial or important, activities 
that are not necessary to support the core functions of treatment 
and payment do require prior patient authorization.
231
 For exam-
ple, the act of selling patients’ PHI could be helpful to a covered 
entity because it could generate income for the covered entity. 
Because selling PHI is not necessary to treat patients or to sup-
port other core functions, the Privacy Rule generally prohibits 
 
 226. See PROTECTED HEALTH INFORMATION, supra note 222, at 39 (emphasis added). 
 227. See Conditions of Participation: Quality Assessment and Performance Improve-
ment Program, 42 C.F.R. § 482.21 (2013) (noting that a federal Medicare condition re-
quires participating hospitals to “develop, implement and maintain an effective, ongoing, 
hospital-wide, data-driven quality assessment and performance improvement program”). 
 228. See, e.g., Illinois Hospital Licensing Act, 210 ILL. COMP. STAT. 85/4 (West 2008) 
(“No person shall establish a hospital without first obtaining a permit from the Depart-
ment [of Public Health].”). 
 229. See, e.g., Ctrs. for Medicare & Medicaid Servs., The Certification Process, in  
STATE OPERATIONS MANUAL (1991), available at http://www.cms.gov/Regulations-and-
Guidance/Guidance/Manuals/Downloads/S0M107c02.pdf (providing information about how 
health care providers and suppliers can become Medicare certified). 
 230. See PROTECTED HEALTH INFORMATION, supra note 222, at 16; Uses and Disclo-
sures for Treatment, Payment, and Health Care Operations, U.S. DEP’T OF HEALTH & 
HUMAN SERVS., at 2 (2003) available at http://www.hhs.gov/ocr/privacy/hipaa/understand 
ing/coveredentities/usesanddisclosuresfortpo.html (explaining that “health care opera-
tions” include the “administrative, financial, legal, and quality improvement activities of a 
covered entity that are necessary to run its business and to support the core functions of 
treatment and payment,” and further explaining that health care operations include quali-
ty assurance, licensing, and certification); see also Standards for Privacy of Individually 
Identifiable Health Information, 67 Fed. Reg. 53,182, 53,208 (Aug. 14, 2002) (to be codified 
at 45 C.F.R. pts. 160, 164) (discussing core functions). 
 231. See HHS on Marketing, supra note 221, at 1 (“With limited exceptions, the Rule 
requires an individual’s written authorization before a use or disclosure of his or her pro-
tected health information can be made for marketing. So as not to interfere with core 
health care functions, the Rule distinguishes marketing communications from those com-
munications about goods and services that are essential for quality health care.”). 
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it.
232
 By further example, the act of marketing products and ser-
vices to patients could be helpful to a covered entity because it 
could generate additional income for the covered entity. Because 
marketing is not necessary to treat patients or to support other 
core functions, the Privacy Rule generally prohibits it without 
prior patient authorization.
233
 
In response to HHS’s 2010 Proposed Rule,
234
 several health care 
providers submitted comments to HHS explaining that philan-
thropy is helpful, beneficial, and important. For example, Yale 
University told HHS that “[i]t would be helpful if [HHS] were to 
allow use of certain broad information, such as the name of the 
clinical department or service that provided care, to assist cov-
ered entities in customizing their fundraising appeals.”
235
 Similar-
ly, Indiana University explained to HHS that “[s]ome types of 
covered entities, such as large, multi-disciplinary health care 
providers or hospitals, may benefit from being able to use addi-
tional information to help identify appropriate recipients of fund-
raising communications.”
236
 Likewise, Beth Israel Deaconess Med-
ical Center told HHS, “This is particularly important to large 
academic medical centers like ours, and would allow us to use our 
very limited resources to better target our fundraising efforts at 
the Medical Center.”
237
 I agree with Yale, Indiana, and Beth Israel 
that philanthropy is helpful, beneficial, and important; however, I 
do not believe philanthropy is a necessary, core function of cov-
ered entities in the same way that treatment, payment, and 
health care operations are.
238
 
 
 232. See Privacy of Individually Identifiable Health Information, 45 C.F.R. § 164.502 
(a)(5)(ii)(A) (2013) (“[Except as permitted] . . . a covered entity or business associate may 
not sell protected health information.”). 
 233. HHS on Marketing, supra note 221, at 1. 
 234. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the 
Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 40,868 
(proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164). 
 235. Letter from Dorothy K. Robinson, Vice President & Gen. Counsel, Yale Univ., to 
Dep’t of Health & Human Servs., Office of Civil Rights 4 (Sept. 13, 2010) (on file with au-
thor) (emphasis added). 
 236. Letter from Marcia N. Gonzales, Exec. Dir. of Research Compliance, Indiana 
Univ., to Dep’t of Health & Human Servs., Office of the Sec’y (Sept. 13, 2010) (on file with 
author) (emphasis added). 
 237. Letter from Kristine C. Laping, Senior Vice President of Dev., Beth Israel Deacon-
ess Med. Ctr., to Kathleen Sebelius, Sec’y, U.S. Dep’t of Health & Human Servs., Office for 
Civil Rights (Sept. 13, 2010) (on file with author) (emphasis added). 
 238. But see Letter from David S. Guzick, Senior Vice President, Health Affairs, Univ. 
of Fla., to Kathleen Sebelius, Sec’y, U.S. Dep’t of Health & Human Servs. Office for Civil 
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The third reason I believe fundraising activities that involve 
non-demographic PHI should require prior patient authorization 
is that fundraisers who prepare and third parties who read tar-
geted fundraising communications that reference patients’ treat-
ing physicians or departments of service could easily determine a 
patient’s diagnosis or the type of health care services requested or 
received. For example, a quick Internet search on my smart 
phone revealed that New York City’s Dr. Nadege M. Coupet spe-
cializes in treating patients infected with the HIV virus,
239
 Las 
Vegas’s Dr. Sheldon Freedman specializes in treating patients 
with sexual dysfunction,
240
 and Phoenix’s Dr. Robert Cohen spe-
cializes in plastic surgery.
241
 A fundraiser who accesses the name 
of a patient’s treating physician to prepare a targeted fundraising 
communication as well as a third party who inadvertently reads 
or receives the targeted communication could easily determine (in 
the time it takes the fundraiser or third party to Google the name 
of the physician on a smart phone) the patient’s general health 
condition or the type of health care services requested or received 
by the patient. Indeed, several individuals who commented on 
HHS’s 1999 Proposed Rule stated that “disease or condition-
specific letters requesting contributions, if opened by the wrong 
person, could reveal personal [health] information about the in-
tended recipient.”
242
 
 
Rights 4 (Sept. 13, 2010) (on file with author) (“Many [covered entities] are non-profits and 
it is essential to their existence that they raise funds from the public . . . .”) (emphasis add-
ed); Letter from Susan Waltman, Exec. Vice President & Gen. Counsel, Greater N.Y. 
Hosp. Assoc., to U.S. Dep’t of Health & Human Servs., Office for Civil Rights (Sept. 13, 
2010) (on file with author) (“Fundraising efforts are crucial to a hospital’s ability to pro-
vide care and treatment to all patients.”) (emphasis added). 
 239. About Dr. Coupet, NADEGE M. COUPET, http://www.drcoupet.com/internal-med 
icine-physician/ (last visited Apr. 14, 2014) (“I am a Board Certified African American 
physician specializing in Internal Medicine and HIV Medicine.”); Health Services, NADEGE 
COUPET, http://www.drcoupet.com/internist-doctor-health-services/hiv-sepcialist-nyc-hiv-in 
fection (last visited Apr. 14, 2014) (“I am an AAHIVM certified HIV specialist with more 
than 14 years experience in treating patients infected with the HIV virus.”). 
 240. Dr. Sheldon J. Freedman, SHELDON J. FREEDMAN, MD LTD., http://www.urology 
channel.com/freedman/physicians.shtml (last visited Apr. 14, 2014) (“His medical practice 
deals with urologic problems in men and women with special emphasis on sexual dysfunc-
tion, urologic oncology, pelvic floor reconstruction, stress incontinence, and stone dis-
ease.”). 
 241. Dr. Robert Cohen, DR. ROBERT COHEN, http://www.robertcohenmd.com/ (last visit-
ed Apr. 14, 2014) (describing Dr. Cohen as a board-certified plastic surgeon who practices 
in Scottsdale, Arizona). 
 242. See Standards for Privacy of Individually Identifiable Health Information, 65 Fed. 
Reg. 82,462, 82,718 (Dec. 28, 2000) (to be codified at 45 C.F.R. pts. 160, 164). 
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In addition to the identity of the patient’s physician, the pa-
tient’s department of service also could reveal the patient’s health 
condition or type of health care services requested or received by 
the patient. For example, a patient who received services in a 
hospital’s oncology department likely has cancer, had cancer, or 
suspects that he or she has cancer. A patient who received ser-
vices in a hospital’s chemical-dependency unit likely has a sub-
stance use disorder, is in recovery from a substance use disorder, 
or suspects that he or she has a substance use disorder. A patient 
who received services in a hospital’s behavioral health unit likely 
has a mental illness, has a history of mental illness, or suspects 
that he or she has a mental illness. With the exception of patients 
who receive negative diagnostic test results, patients do not gen-
erally request or receive services from a particular department or 
unit unless they require such services. In addition, patients who 
suspect that they have certain illnesses, including mental illness-
es, sexually transmitted diseases, and other sensitive conditions, 
are as deserving of confidentiality as individuals who are diag-
nosed with such illnesses. 
In summary, fundraisers who have access to the identity of the 
patient’s treating physician and the patient’s department of ser-
vice may be able to determine the patient’s diagnosis or type of 
health care services requested or received. In addition, a targeted 
fundraising letter sent to a patient’s home that is specific as to 
the identity of the patient’s treating physician or department of 
service can suggest the diagnosis of the patient or the type of 
health care services requested or received to any third party who 
intentionally or inadvertently happens to read or see the letter. 
For these reasons, I argue that the patient’s prior written author-
ization should be obtained before a covered entity uses or disclos-
es the name of the patient’s treating physician or the patient’s 
department of service for fundraising purposes.
243
 
The fourth reason I argue fundraising activities that use a pa-
tient’s non-demographic PHI should require prior authorization is 
that a close examination of the comments received by HHS in re-
sponse to its 2010 Proposed Rule do not indicate a shift in public 
 
 243. See AM. MED. ASS’N, COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS, PHYSICIAN 
PARTICIPATION IN SOLICITING CONTRIBUTIONS FROM PATIENTS CEJA REP. 7-A-04, at 3 
(2004) (stating that a physician who sends “personalized solicitation letters to patients’ 
homes where others may notice them, or [a physician who communicates] patient infor-
mation to third parties,” including fundraisers, may undermine confidentiality). 
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attitudes regarding the proper balance of confidentiality and phi-
lanthropy. Rather, the comments indicate that covered entities 
continue to want to gather, use, and disclose as much PHI as pos-
sible for fundraising purposes while patients’ rights advocates 
and privacy coalitions continue to want to prioritize health infor-
mation confidentiality. The fact that covered entities continue to 
want to gather, use, and disclose expanded classes of PHI for 
fundraising does not mean that philanthropy should, on a norma-
tive level, outweigh basic patients’ rights. Rather, as discussed in 
more detail in Part V, I propose that health information confiden-
tiality and health care philanthropy be balanced through a more 
express notification of fundraising activities and a prior written 
authorization requirement. 
In response to its 2010 Proposed Rule, HHS received 306 com-
ments totaling 2030 pages.
244
 Sixty-one of these comments con-
tained the word “fundraising,”
245
 although not all of these sixty-
one comments discussed the Privacy Rule’s fundraising require-
ments in detail. Fifty-five of these sixty-one comments were au-
thored by health care providers, institutionally related founda-
tions, other fundraising organizations, medical societies, health 
plans, and health care attorneys, while six of these comments 
were authored by patients’ rights advocates, privacy coalitions, 
health information management organizations, and a professor 
and his students in an ethics class at a graduate business 
school.
246
 
In its 2010 Proposed Rule, HHS did not ask the public to care-
fully balance a patient’s right to confidentiality with a health care 
provider’s desire to engage in grateful patient fundraising. The 
only question HHS asked the public to consider was the narrow 
question of whether the Privacy Rule’s fundraising provisions 
should be loosened to allow covered entities to access a broader 
 
 244. Health Information Technology for Economic and Clinical Health Act: Modifica-
tions to the HIPAA Privacy, Security, and Enforcement Rules, REGULATIONS.GOV (Sept. 13, 
2010), http://www.regulations.gov/#!docketDetail;D=HHS-OCR-2010-0016 (downloaded 
individually and combined into one consecutively paginated document). 
 245. A search within the 306 comments for the word “fundraising” revealed sixty-four 
comments. Id. Three of these comments, including those from the College of Healthcare 
Information Management Executives, the California Hospital Association, and the World 
Privacy Forum, appear to be duplicative, leaving sixty-one non-duplicative comments that 
contain the word “fundraising.” See id.  
 246. Id. 
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class of PHI, including a patient’s department of service, without 
the patient’s prior authorization.
247
 
The majority of the very small number of health care providers 
and related organizations who responded supported the ability to 
access treating physician, department of service, and health out-
come information without prior patient authorization. The Great-
er New York Hospital Association (“GNYHA”), for example, sup-
ported HHS’s proposal to allow department of service information 
to be used and disclosed without prior authorization.
248
 According 
to GNYHA, “This approach would allow hospitals to narrow their 
target audience, [and] provide a clear fundraising message . . . .”
249
 
The Council for Advancement and Support of Education 
(“CASE”), a leader in educational fundraising, also stated that ac-
cess to additional categories of PHI would “strengthen grateful 
patient fundraising and reduce costly and ineffective fundraising 
communications.”
250
 CASE further explained that “[t]he current 
restrictions limit the ability of college, university and foundation 
fundraisers to effectively target their fundraising communica-
tions and provide patients a meaningful opportunity to support 
their areas of care.”
251
 
Other health care providers also expressed their desire for ac-
cess to treating physician and department of service information 
without prior patient authorization. Providence Health & Ser-
vices stated that “health care fundraising efforts could be 
strengthened and streamlined with access to department of ser-
vice or generic areas of treatment information.”
252
 The Johns 
 
 247. HHS specifically stated: “In particular, we solicit comment on: (1) Whether the 
Privacy Rule should allow additional categories of protected health information to be used 
or disclosed for fundraising, such as department of service or similar information, and if 
so, what those categories should be.” Modifications to the HIPAA Privacy, Security, and 
Enforcement Rules Under the Health Information Technology for Economic and Clinical 
Health Act, 75 Fed. Reg. 40,868, 40,897 (proposed July 14, 2010) (to be codified at 45 
C.F.R. pts. 160, 164). 
 248. Letter from Susan Waltman, Exec. Vice President & General Counsel, Greater 
N.Y. Hosp. Ass’n, to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 3 (Sept. 
13, 2010) (on file with author). 
 249. Id.  
 250. Letter from John Lippincott, President, Council for Advancement & Support of 
Education, to Office of the Sec’y, U.S. Dep’t of Health & Human Servs. 3 (Sept. 10, 2010) 
(on file with author) . 
 251. Id. at 3–4. 
 252. Letter from John Koster, President & Chief Exec. Officer, Providence Health & 
Servs., to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 2 (Sept. 13, 2010) 
(on file with author). 
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Hopkins Health System agreed: “[I]n addition to the patient’s de-
partment of service, fund-raising efforts [should] be allowed to 
use the name of the treating physician by the development office 
or foundation without the necessity of an authorization.”
253
 The 
Federation of American Hospitals shared Johns Hopkins’ view 
that fundraising “is an important function, particularly for non-
profit institutions, and we believe that liberalization of the rules 
in this area would not compromise the interests of individuals.”
254
 
The problem is that these comments did not advance the real 
question at hand of how to properly balance the need to protect 
patient confidentiality with providers’ desire to use and disclose 
PHI for philanthropic purposes. The bulk of the comments sub-
mitted simply reinforce the viewpoint of health care providers 
and fundraisers that access to a larger subset of PHI could ease 
their fundraising efforts. 
It is not surprising that comments authored by patients’ rights 
advocates and privacy coalitions expressed the opposing view-
point. The World Privacy Forum firmly told HHS that “[s]haring 
any health information with a fundraiser is a gross violation of 
privacy.”
255
 The World Privacy Forum explained: “Telling a fund-
raiser that the patient was treated by a particular department 
can be tantamount to disclosing the diagnosis. Sharing outcomes 
information is just as bad.”
256
 Less upset, but still firm, was the 
State of California Office of Health Information Integrity: “The 
State of California is not in favor of allowing additional categories 
of PHI to be used or disclosed for fundraising.”
257
 
 
 253. Letter from Donald L. Bradfield, Senior Counsel, the Johns Hopkins Health Sys., 
to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 2 (Sept. 13, 2010) (on file 
with author). 
 254. Letter from Fed’n of Am. Hosps., to the Honorable Kathleen Sebelius, Sec’y, U.S. 
Dep’t of Health & Human Servs. 5 (Sept. 13, 2010) (on file with author). 
 255. Letter from Pam Dixon, Exec. Dir., World Privacy Forum, to the U.S. Dep’t of 
Health & Human Servs., Office for Civil Rights 14 (Sept. 13, 2010) (on file with author) 
(emphasis added). 
 256. Id. World Privacy Forum further stated: “Consider a person who had told no 
friend or family of her cancer treatment who subsequently receives a call from a stranger 
who knows about that treatment. How can any such use be justified under any circum-
stances? . . . Imagine that a hospital hired a business associate to do fundraising and that 
you received a call from a neighbor, cousin, or colleague working for that fundraiser who 
knew that you were treated by the oncology department?” Id.  
 257. STATE OF CAL., COMMENTS TO THE HIPAA PRIVACY, SECURITY & ENFORCEMENT 
NPRM 14 (Sept. 13, 2010) (on file with author). 
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The bipartisan Coalition for Patient Privacy agreed that confi-
dentiality should trump philanthropy, and argued that patients 
should have to affirmatively opt in to the receipt of fundraising 
communications, citing the need to preserve the confidentiality of 
sensitive health information.
258
 The Center for Democracy and 
Technology (“CDT”) agreed with the Coalition for Patient Privacy; 
that is, CDT wanted HHS to “[e]stablish an opt in standard for 
fundraising communications to patients that use PHI beyond de-
mographics and dates of service.”
259
 
The College of Healthcare Information Management Execu-
tives similarly urged HHS to retain its current policy and “not at-
tempt to enhance fundraising opportunities,” citing the opera-
tional difficulty of distinguishing between broad designations, 
such as department of service, and narrow designations, such as 
diagnosis, because the department of service (e.g., oncology) could 
suggest the patient’s diagnosis (i.e., cancer).
260
 
Finally, a professor and several of his students in an Ethics for 
the Law Office Class at the Minnesota School of Business would 
require prior patient authorization for fundraising. The class 
stated, “We recognize the need for . . . funding for new medical 
equipment and technology . . . but in achieving that goal, we 
should not compromise private health information . . . .”
261
 
Given that HHS only solicited public comment on the narrow 
question of “[w]hether the Privacy Rule should allow additional 
categories of protected health information to be used or disclosed 
for fundraising, such as department of service or similar infor-
mation,” the polarized comments referenced above are not sur-
prising.
262
 Health care providers want access to treating physician 
 
 258. Letter from Coal. for Patient Privacy, to the Honorable Kathleen Sebelius, Sec’y, 
U.S. Dep’t of Health & Human Servs., Office of Civil Rights 18 (Sept. 13, 2010) (on file 
with author). 
 259. Letter from Ctr. for Democracy & Tech. to Georgina Verdugo, Dir., Office for Civil 
Rights, U.S. Dep’t of Health & Human Servs. 26 (Sept. 13, 2010) (on file with author). 
 260. Letter from Richard A. Correll, President & CEO, Coll. of Healthcare Info. Mgmt. 
Execs., to Georgina Verdugo, Dir., Office for Civil Rights, U.S. Dep’t of Health & Human 
Servs. 5 (Sept. 13, 2010) (on file with author). 
 261. Letter from Maria Greilinger, Tamara Daugherty, Marie Thorp, Roberta Kurth, & 
Alan Witz, Ethics for the Law Office Class, Minnesota Sch. of Bus., to U.S. Dep’t of Health 
& Human Servs., Office for Civil Rights 3 (on file with author). 
 262. Modifications to the HIPAA Privacy, Security, and Enforcement Rules Under the 
Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. 40,868, 
40,897 (proposed July 14, 2010) (to be codified at 45 C.F.R. pts. 160, 164). 
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and department of service information to ease their fundraising 
efforts whereas patients’ rights advocates and privacy coalitions 
do not want PHI, other than basic demographic information, to be 
used or disclosed for fundraising. Each comment submitted re-
flected one of these two opposing positions. Perhaps if HHS had 
asked for ideas regarding how to “better balance health infor-
mation confidentiality with health care philanthropy,” or “how to 
best preserve patient confidentiality while supporting health care 
philanthropy,” the comments might have been more nuanced. Not 
one health care provider who submitted a comment could even ar-
ticulate one reason why philanthropy should trump confidentiali-
ty other than easing covered entities’ fundraising efforts. Not one 
health care provider who submitted a comment seriously ana-
lyzed the confidentiality concerns raised by grateful patient fund-
raising and other health care philanthropy initiatives. 
Again, HHS’s solicitation of comments on the narrow question 
of whether access to additional PHI would make grateful patient 
fundraising easier is partly to blame. Also blameworthy is admin-
istrative law’s notice-and-comment rulemaking process.
263
 Alt-
hough a rich discussion of all of the problems associated with the 
notice-and-comment rulemaking process is beyond the scope of 
this article, a quick discussion of two illustrative problems might 
help put the content of the Final Regulations in context. 
First, although proposed rules are supposed to be vehicles for 
policymaking, many policy decisions are made well before the rel-
evant agency ever issues a proposed rule.
264
 Indeed, when HHS in 
its 2010 Proposed Rule quietly solicited public comment on 
whether to expand the classes of PHI that could be used and dis-
closed for fundraising without prior patient authorization,
265
 HHS 
did not appear to be introducing a potential new policy the merits 
of which could be considered by the public for the first time. In-
stead, HHS appeared to be adopting the September 2004 policy 
recommendation of the National Committee on Vital and Health 
Statistics (“NCVHS”) that a patient’s department of service could 
 
 263. The Regular Rulemaking Process, OFF. OF ADMIN. L., http://www.oal.ca.gov/regu 
lar_Rulemaking_Process.htm (last visited April 14, 2014). 
 264. See Richard Murphy, Enhancing the Role of Public Interest Organizations in 
Rulemaking via Pre-Notice Transparency, 47 WAKE FOREST L. REV. 681, 682 (2012). 
 265. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under 
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at 
40,897. 
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be used and disclosed for fundraising purposes without prior au-
thorization.
266
 The NCVHS recommendations were based in part 
on a July 2004 hearing where the NCVHS heard testimony from 
representatives of AHP, an academic medical center, and a priva-
cy institute.
267
 Not surprisingly, AHP and the academic medical 
center were in favor of expanding the classes of PHI that could be 
used and disclosed for fundraising purposes without prior patient 
authorization whereas the privacy institute favored requiring 
prior patient authorization.
268
 Without any attempt to balance 
these two positions, the NCVHS (in a letter authored by its phy-
sician chair) simply decided to adopt the pro-philanthropy per-
spective articulated by AHP and the academic medical center.
269
 
Six years later, HHS in its 2010 Proposed Rule referenced the 
NCVHS recommendations en route to proposing the loosening of 
confidentiality in the context of health care philanthropy.
270
 
In summary, the 2010 Proposed Rule should have been the ini-
tial vehicle for new policymaking relating to patient confidentiali-
ty in the context of fundraising. However, I suggest that HHS 
made its policy decision back in 2004, after receiving the NCVHS 
recommendations, and simply used the 2010 Proposed Rule (in-
cluding the Rule’s very narrow request for comments) and the 
 
 266. Letter from John R. Lumpkin, Chairman, Nat’l Comm. on Vital & Health Statis-
tics, to the Honorable Tommy G. Thompson, Sec’y, U.S. Dep’t of Health & Human Servs. 
(Sept. 2, 2004), available at http://www.ncvhs.hhs.gov/020425lt.htm. 
 267. Id. 
 268. Id. 
 269. Id. 
 270. See Modifications to the HIPPA Privacy, Security, and Enforcement Rules Under 
the Health Information Technology for Economic and Clinical Health Act, 75 Fed. Reg. at 
40,897  (“NCVHS also held a hearing and heard public testimony on this issue in July 
2004. After considering the testimony provided, the NCVHS recommended to the Secre-
tary that the Privacy Rule should allow covered entities to use or disclose information re-
lated to the patient’s department of service (broad designations, such as surgery or oncolo-
gy, but not narrower designations or information relating to diagnosis or treating 
physician) for fundraising activities without patient authorization. NCVHS also recom-
mended that a covered entity’s notice of privacy practices inform patients that their de-
partment of service information may be used in fundraising, and that patients should be 
afforded the opportunity to opt out of the use of their department of service information for 
fundraising or all fundraising contacts altogether. . . . In light of these concerns and the 
prior recommendation of the NCVHS, the Department takes this opportunity to solicit 
public comment on whether and how the current restriction on what information may be 
used and disclosed should be modified to allow covered entities to more effectively target 
fundraising and avoid inappropriate solicitations to individuals, as well as to reduce the 
need to send solicitations to all patients.”). 
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2013 Final Regulations to establish a formal administrative rec-
ord should the Final Regulations become the subject of later judi-
cial review. 
A second problem with notice-and-comment rulemaking is that 
its process can favor well-resourced industry participants. When 
a particular regulatory action threatens the interests of an entire 
industry, the participants in that industry can collectively invest 
in attorneys, consultants, lobbyists, and politicians to protect 
their interests. In the health care industry, heavily regulated 
health care providers, health plans, and their professional associ-
ations frequently join forces to create professional, legal respons-
es to proposed rules that can be signed and submitted by all of 
the members of the industry or that can be copied and personal-
ized by industry members and individually submitted. The result 
is that HHS receives dozens of comments that support the same 
position whenever it attempts to regulate the health care indus-
try. In response to the 2010 Proposed Rule, for example, the AMA 
joined forces with thirty-six other major medical societies, associ-
ations, and academies to submit a powerful, joint comment to 
HHS.
271
 By further example, the AHP submitted its own thirteen-
page, single-spaced comment to HHS
272
 that AHP’s members, in-
cluding the Mary Bird Perkins Cancer Center and the Beth Israel 
Deaconness Medical Center, then re-submitted and referenced,
273
 
respectively. 
Notwithstanding the intellect and energy of patients’ rights 
advocates and privacy coalitions such as the Coalition for Patient 
Privacy
274
 and the World Privacy Forum,
275
 their legal, financial, 
 
 271. See Letter from Mari Savickis, Am. Med. Ass’n, to the Honorable Kathleen Sebe-
lius, Sec’y, U.S. Dep’t of Health & Human Servs., Office for Civil Rights (Sept. 13, 2010), 
available at http://wwwregulations.gov/#!documentDetail;D=HHS-OCR-2010-0016-0173. 
 272. See Letter from William C. McGinly, President & CEO, Ass’n for Healthcare Phi-
lanthropy, to Dep’t of Health & Human Servs., Office of the Sec’y (Sept. 13, 2010), availa-
ble at http://www.regulations.gov/#!documentDetail;D=HHS-OCR-2010-0016-0137. 
 273. See Comment from Amy Benton, Mary Bird Perkins Cancer Ctr., to U.S. Dep’t of 
Health & Human Servs. (Sept. 13, 2010), available at http://www.regulations.gov/#!docu 
mentDetail;D=HHS-OCR-2010-0016-0122  (attaching the AHP’s comment and stating, 
“Mary Bird Perkins Cancer Center and Mary Bird Perkins Cancer Center Foundation ful-
ly support the Association for Healthcare Philanthropy’s (AHP) position . . . . We have at-
tached AHP’s comments”); see Letter from Kristine C. Laping, supra note 237, at 2 (“We 
share the concerns expressed by the Association for Healthcare Philanthropy . . . .”). 
 274. Coalition for Patient Privacy, PATIENT PRIVACY RIGHTS, http://patientprivacy 
rights.org/coalition-patient-privacy/ (last visited Apr. 14, 2014). 
 275. About Us, WORLD PRIVACY FORUM, http://www.worldprivacyforum.org/about-us. 
html (last visited April 14, 2014). 
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and other resources pale in comparison to the resources of the 
likes of Yale University,
276
 Stanford University,
277
 and Beth Israel 
Deaconess Medical Center,
278
 as well as the nation’s other out-
standing academic medical centers and medical institutions. Pa-
tients’ rights advocates and privacy coalitions simply lack the re-
sources to launch a comparable fight, including the resources to 
submit high numbers of professional, persuasive comments. 
One result is that agencies such as HHS usually receive more 
comments from industry participants than from the non-
regulated public. Again, in response to its 2010 Proposed Rule, 
HHS received approximately fifty-five comments from the health 
care industry that contained the word “fundraising.” In compari-
son, HHS received only six comments from patients’ rights organ-
izations, privacy coalitions, health information management or-
ganizations, and an ethics class at a graduate business school. In 
its Final Regulations, HHS explained that these numbers were 
persuasive: “[T]he vast majority of commenters supported allow-
ing the use or disclosure of additional protected health infor-
mation for fundraising” and “a small minority of commenters op-
posed allowing the use of additional protected health information 
to target fundraising efforts, citing privacy concerns with doing 
so.”
279
 Given that the notice-and-comment rulemaking process can 
favor industry, I argue that simply counting the (relatively small 
number of) comments submitted on behalf of the nation’s hun-
dreds of thousands of health care providers that make up the $2.7 
trillion health care industry
280
 and comparing that number to the 
number of comments submitted by patients’ rights and privacy 
coalitions is not a reason to favor philanthropy over confidentiali-
 
 276. See Letter from Dorothy K. Robinson, supra note 235. 
 277. See Letter from Privacy Officer, Dir. of Research Compliance, & Privacy & Sec. 
Officers, Stanford Univ., to U.S. Dep’t of Health & Human Servs., Office for Civil Rights 
(Sept. 13, 2010), available at http://www.regulations/gov/#!documentDetail;D=HHS-OCR-
2010-0016-0263. 
 278. See Letter from Kristine C. Laping, supra note 237, at 1. 
 279. Modifications to the HIPAA Privacy, Security, Enforcement, and Breach Notifica-
tion Rules under the Health Information Technology for Economic and Clinical Health Act 
and the Genetic Information Nondiscrimination Act, 78 Fed. Reg. 5566, 5620 (Jan. 25, 
2013) (to be codified at 45 C.F.R. pts. 160, 164). According to HHS, “These commenters 
stated that the use of additional protected health information would streamline their 
fundraising efforts and ensure that individuals were sent communications about cam-
paigns that would be meaningful to their experiences.” Id. 
280. Elisabeth Rosenthal, The $2.7 Trillion Medical Bill: Colonoscopies Explain Why 
U.S. Leads the World in Health Expenditures, N.Y. TIMES, June 2, 2013, at A1 (referencing 
the nation’s $2.7 trillion annual health care bill). 
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ty. Instead, I suggest that the notice-and-comment rulemaking 
process favors well-resourced industry participants.
281
 To me, the 
comments simply indicate that covered entities continue to want 
to gather, use, and disclose PHI about patients for fundraising 
purposes while patients’ rights advocates and privacy coalitions 
continue to want to prioritize confidentiality. The fact that cov-
ered entities continue to want to gather, use, and disclose PHI for 
fundraising does not mean that philanthropy should, on a norma-
tive level, outweigh basic patients’ rights. Rather, and as dis-
cussed in more detail in the final Part of this article, I propose 
that health information confidentiality and health care philan-
thropy be balanced through a more express notification of fund-
raising and authorization requirement. 
V.  A PROPOSAL 
In this final Part, I examine three options for the future regula-
tion of the use and disclosure of PHI for fundraising and select 
the option that I believe creates the best balance between health 
care philanthropy and health information confidentiality. 
One option is to revise the Final Regulations to prohibit all 
grateful patient fundraising. If grateful patient fundraising risks 
breach of confidentiality (and a range of other ethical issues in-
cluding conflicted decision making, health care resource alloca-
tion injustices, financial exploitation, and breach of privacy),
282
 
then one approach is to eliminate grateful patient fundraising in 
its entirety. This option could be implemented by deleting the 
language currently codified at 45 C.F.R. § 164.514(f)(1)–(2) or by 
deleting such language and replacing it with: 
(f) Fundraising communications. A covered entity may not use, or 
disclose to a business associate or to an institutionally related foun-
dation, any protected health information for fundraising or philan-
thropic purposes. 
I disagree with this approach. As discussed in detail in Part III, 
philanthropy supports a wide variety of important health care in-
itiatives and related educational missions. Academic medical cen-
 
 281. See Murphy, supra note 264, at 683 (“Thus, it is possible that changes made to the 
rulemaking process that were intended, in part, to enable strong public interest group par-
ticipation may often disfavor such groups.”). 
 282. See generally Tovino, Giving Thanks, supra note 9 (discussing the ethical issues 
raised by physician involvement in grateful patient fundraising). 
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ters rely on philanthropy to satisfy educational needs, research 
programs, clinical initiatives, and building and infrastructure 
support. Non-profit health care organizations engage in fundrais-
ing to provide resources to their community-based hospitals and 
clinics and to improve access to health care and other services for 
the uninsured and under-insured. Private health care founda-
tions use philanthropy to serve the economically poor and under-
served, including women, children, and seniors who live in the 
community served by the foundation. Health care philanthropy, 
which totaled $28.12 billion in 2012,
283
 cannot be eliminated in its 
entirety. 
A second option is to maintain the status quo. That is, a second 
option is to: (1) keep the language in the Final Regulations allow-
ing covered entities to use and disclose treating physician and 
department of service information without prior patient authori-
zation; and (2) support our current approach to health care phi-
lanthropy which relies on significant physician involvement in 
grateful patient fundraising. As discussed in significant detail 
elsewhere, I dislike this option because it provides insufficient 
protection of the physician-patient relationship and risks conflict-
ed decision making, health care resource allocation injustices, fi-
nancial exploitation, breach of privacy, and breach of confidential-
ity.
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A third option is to allow grateful patient fundraising to pro-
ceed with some limitations that are designed to protect health in-
formation confidentiality and other basic patients’ rights. This op-
tion, which I support, would require: (1) the revision of the Final 
Regulations to better protect health information confidentiality; 
and (2) the adoption of a complementary set of ethical guidelines 
governing physician involvement in grateful patient fundrais-
ing.
285
 
In terms of revising the Final Regulations, I first propose that 
covered entities not be allowed to use or disclose treating physi-
cian and department of service information without prior patient 
authorization. Thus, I propose that 45 C.F.R. § 164.514(f)(1) be 
revised to read: 
 
 283. Charitable Giving Rose 3.5 Percent in 2012, GIVING USA (June 20, 2013), http:// 
www.givingusareports.org/news-and-events/news.aspx?NewsTypeId=3& NewsId=182. 
 284. See generally Tovino, Giving Thanks, supra note 9. 
 285. See id. (adopting a complementary set of ethical guidelines). 
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(f) Fundraising communications. (1) Standard: Uses and disclosures 
for fundraising. Subject to the conditions of paragraph (f)(2) of this 
section, a covered entity may use, or disclose to a business associate 
or to an institutionally related foundation, the following protected 
health information for the purpose of raising funds for its own bene-
fit, without an authorization as defined in paragraph (f)(3): 
(i)  Demographic information relating to an individual, includ-
ing name, address, other contact information, age, gender, and 
date of birth; 
(ii)  Dates of health care provided to an individual; and 
(iii) Health insurance status. 
Second, and in conjunction with the ethical proposals made in 
the companion article, I propose that 45 C.F.R. § 164.514(f)(2)(i) 
be revised to require patients be notified regarding whether the 
covered entity will be conducting wealth screenings and other in-
formation searches using publicly or commercially available in-
formation: 
(f)(2) Implementation specifications: Fundraising requirements. 
(i) A covered entity may not use or disclose protected health in-
formation for fundraising purposes as otherwise permitted by 
paragraph (f)(1) of this section unless: (a) a statement required 
by 164.520(b)(1)(iii)(A) is included in the covered entity’s notice 
of privacy practices; and (b) a statement indicating whether 
the covered entity will conduct patient wealth screenings and 
other information searches using publicly or commercially 
available information is included in the covered entity’s notice 
of privacy practices. 
In turn, 45 C.F.R. § 164.520(b)(1)(iii)(A), which describes the 
way in which patients should be alerted to uses and disclosures of 
their PHI for fundraising through the notice of privacy practices, 
should be amended to provide: 
(b)(1)(iii) Separate statements for certain uses or disclosures. If the 
covered entity intends to engage in any of the following activities, 
the description required by paragraph (b)(1)(ii)(A) of this section 
must include a separate statement informing the individual of such 
activities, as applicable: 
(A) In accordance with § 164.514(f)(1), the covered entity may, 
without prior written authorization, use and disclose to institu-
tionally-related foundations and associates the information 
listed at paragraph (f)(1)(i)–(iii), as long as the covered entity 
provides information regarding how the individual may opt out 
of these information uses and disclosures. In accordance with § 
164.514(f)(3), the covered entity may, but only with prior writ-
ten authorization, use and disclose to institutionally-related 
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foundations and business associates protected health infor-
mation other than the information listed at paragraph (f)(1)(i), 
together with information regarding how the individual may 
authorize such uses and disclosures. 
Third, I propose adding a new 45 C.F.R. § 164.514(f)(3) to the 
end of the fundraising regulation. This new subsection would es-
tablish standard fundraising notification and authorization lan-
guage that covered entities would use to notify patients regarding 
their philanthropy activities and obtain their patients’ prior writ-
ten authorization. The new subsection would provide: 
(f)(3) Fundraising notification and authorization. A covered entity 
may use or disclose protected health information in addition to the 
information listed at paragraph (f)(1)(i)–(iii) for fundraising purposes 
only if the covered entity provides express written notification to the 
patient regarding the means the covered entity uses to obtain phil-
anthropic donations and obtains the individual’s prior written au-
thorization to such means. A valid fundraising notification and au-
thorization must include at least the following elements: 
(A) The name and address of the covered entity; 
(B) A statement that the covered entity uses patient fundrais-
ing to support clinical initiatives, educational missions, or oth-
er health care or educational goals, as appropriate; 
(C) A description of the means the covered entity uses to obtain 
philanthropic donations, including a description of any physi-
cian involvement in grateful patient fundraising, development 
office involvement in grateful patient fundraising, institution-
ally-affiliated foundation involvement in fundraising, inde-
pendent contractor or business associate involvement in fund-
raising, the conduct of wealth screenings, and similar 
measures; 
(D) A description of the specific classes of protected health in-
formation, such as treating physician and department of ser-
vice information, that the patient is authorizing the covered 
entity to use and disclose for fundraising purposes; 
(E) The name(s) of any employed, affiliated, or contracted 
fundraisers with whom these classes of protected health infor-
mation will be shared or to whom these classes of protected 
health information will be disclosed; 
(F) A statement that employed, affiliated, and contracted fund-
raisers may not further use or disclose protected health infor-
mation other than for fundraising purposes; 
(G) A statement that employed, affiliated, and contracted fund-
raisers are subject to regulation by the federal HIPAA Privacy 
Rule and are subject to civil and criminal penalties for unau-
thorized uses and disclosures of protected health information; 
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(H) A statement that the covered entity’s primary relationship 
with the patient is a treatment relationship, not a philanthrop-
ic relationship; 
(I) A general statement that the covered entity may not condi-
tion treatment, payment, or health care operations on a fund-
raising authorization or philanthropic donation; 
(J) A specific statement that the covered entity may not vary 
the provision, timing, quality, or quantity of treatment on a 
fundraising authorization or philanthropic donation; 
(K) A statement regarding how the individual may contact the 
covered entity’s Privacy Official to discuss concerns regarding 
fundraising. This statement shall include the postal address, 
telephone number, and email address of the covered entity’s 
Privacy Official; 
(L) A statement regarding how the individual may contact the 
federal Department of Health and Human Services (“HHS”) to 
complain and report a breach of confidentiality by either the 
covered entity or a contracted fundraiser. This statement shall 
include a link to HHS’s “How to File a Complaint” Web page, 
available at http://www.hhs.gov/ocr/privacy/hipaa/complaints/; 
and 
(M) Signature of the individual and date. If the authorization 
is signed by a personal representative of the individual, a de-
scription of such representative’s authority to act for the indi-
vidual must also be provided. 
Fourth, I propose that HHS revise its Model Notice, which cur-
rently contains the following superficial statement: “In the case of 
fundraising: We may contact you for fundraising efforts, but you 
can tell us not to contact you again.”
286
 The Model Notice should 
be revised to provide: 
In the case of fundraising: 
Without your prior written authorization, we may internally 
use and disclose to institutionally-related foundations and 
business associates certain demographic information (includ-
ing name, address, other contact information, age, gender, and 
date of birth), dates of health care provided to you, and infor-
mation regarding your health insurance status. You may opt 
out of these unauthorized information uses and disclosures by 
contacting the Privacy Official at the following [email address], 
[physical mailing address], or [telephone number]. 
Only with your prior written authorization, we may internal-
ly use and disclose to institutionally-related foundations and 
business associates protected health information other than 
demographic information, dates of health care, and health in-
 
 286. MODEL NOTICE, supra note 5, at 4. 
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surance status. You may authorize such uses and disclosures 
by contacting the [Name of Covered Entity] Privacy Official at 
the following [email address], [physical mailing address], or 
[telephone number]. 
CONCLUSION 
Philanthropy plays an important role in the American health 
care system. Due to high uncompensated health care costs, inad-
equate Medicare and Medicaid reimbursement, rising health care 
compliance costs associated with health care reform, and expen-
sive medical equipment, many health care institutions depend on 
philanthropic donations. For these reasons, health care philan-
thropy should be encouraged. 
One concern with health care philanthropy is its reliance on 
the use and disclosure of patient identifiable information and the 
associated risk of breach of confidentiality. This concern can be 
lessened through the proper regulation of the use and disclosure 
of protected health information for fundraising. To this end, this 
article critiques and proposes corrections to Privacy Rule and 
Model Notice provisions that govern the permissible scope of uses 
and disclosures of protected health information for fundraising 
purposes. These regulatory proposals are designed to support 
health care philanthropy while protecting a patient’s right to 
health information confidentiality. 
